Explore every episode of the podcast Global Medical Device Podcast powered by Greenlight Guru

In this episode of the Global Medical Device Podcast, Etienne Nichols sits down with Subhi Saadeh, host of the Combinate Podcast and an expert in the field of combination products.

They explore the complexities of combination products—those that integrate drugs, devices, and biologics—highlighting the regulatory challenges and industry growth.

Subhi shares his personal journey in podcasting, the impact of consistent content production, and the importance of lifelong learning.

They also dive into the intricacies of combination product definitions, regulatory pathways, and trends, offering listeners a well-rounded view of the current state and future potential of this evolving industry.

• [00:02] – Introduction of Subhi Saadeh and his background in combination products.
• [03:45] – The origin story of the Combinate Podcast and its impact on Subhi’s career.
• [12:32] – Overview of combination products and regulatory differences between the US and EU.
• [18:50] – Common misconceptions in drug-device integration.
• [28:10] – The evolving landscape of combination products and industry growth.
• [34:22] – Balancing technical and business aspects in MedTech.
• [46:15] – Notable episodes and guests from the Combinate Podcast.
• [56:30] – Final thoughts on lifelong learning and producing valuable content.

• Subhi Saadeh: "If I want to be a master at my craft, I need to be producing something in a way that is consistent."
• Etienne Nichols: "Teaching others is one of the best ways to instill that knowledge into yourself."
• Subhi Saadeh: "Drugs and devices aren’t as different as people think; it’s how they measure product quality that varies."

• Combinate Podcast: let’s combinate.com
• Subhi Saadeh’s LinkedIn Profile: Connect with Subhi
• FDA Regulatory Guidelines for Combination Products: Important for understanding the regulatory landscape.
• Book Reference: Quality is Free by Philip Crosby - A must-read for quality management professionals.
• Book Reference: Bottle of Lifes by Katherine Eban
• Etienne Nichols’ LinkedIn Profile:

Explore the essential role of quality management in small medical device companies with Vernon Baker, a seasoned engineer. Learn about core QMS activities, regulatory intelligence, effective communication with top management, and key skills for aspiring quality managers. Gain valuable insights on supplier management, risk assessment, and regulatory compliance for startups and growing medical device firms.

In this episode of the Global Medical Device Podcast, Etienne Nichols hosts Laura Maher to discuss the critical role of design assurance in medical device development.

They explore the importance of ownership in design and development documentation, delve into the complexities of design controls, and share practical insights on how to ensure compliance and streamline product development.

Laura shares her unique journey from quality control to product development, emphasizing the need for a multidisciplinary approach to create effective and safe medical devices.

• [00:00] - Introduction and Sponsor Messages
• [03:10] - Introducing Laura Maher and her background
• [06:45] - Who should own design and development documentation?
• [12:20] - The importance of understanding design controls
• [18:35] - The role of design assurance professionals
• [25:50] - Audience of design and development documentation
• [33:40] - The intersection of quality and product development
• [40:55] - Differences between design reviews and stage reviews
• [47:15] - Collaborative nature of risk management
• [55:30] - Essential skills for a design assurance professional
• [1:02:40] - Closing thoughts and resources

• "The value of design assurance professionals lies in their ability to bridge the gap between quality and development." - Laura Maher
• "Understanding the spirit of quality and innovation is as important as knowing the definitions in design controls." - Etienne Nichols
• "A design file is not just for launch; it’s a living document that supports the entire lifecycle of a device." - Laura Maher

1. Multidisciplinary Approach: Combining quality, regulatory, and product development knowledge is crucial for effective design assurance.
2. Documentation Ownership: Assigning clear ownership of design documentation can streamline development and ensure compliance.
3. Design Controls Understanding: A deep understanding of design controls helps in creating documentation that satisfies regulatory requirements and is audit-ready.

1. Training and Education: Seek out training programs on design controls and quality management to build foundational knowledge.
2. Collaboration: Foster a collaborative environment where engineers, quality assurance, and regulatory teams work together on documentation.
3. Technical Writing: Develop strong technical writing skills to create clear and comprehensive design documentation.

• Greenlight Guru - Quality management software tailored for medical devices.
• Rook Quality Systems - Comprehensive compliance services for medical device companies.
• Ultimate Guide to Bringing a Medical Device to Market - A detailed resource for new and experienced MedTech professionals.

Design Controls: A set of practices and procedures for managing the design of medical devices to ensure they meet user needs and regulatory requirements.

Trace Matrix: A document that maps user needs to design inputs and outputs, ensuring all requirements are met.

Risk Management:...

In this episode of the Global Medical Device Podcast, Etienne Nichols sits down with Dr. Matthew Wettergreen, Director of the Global Medical Innovation Master of Bioengineering program at Rice University. Dr. Wettergreen shares his extensive experience in developing client-based engineering design courses and discusses the importance of global and contextual perspectives in medical device innovation. They delve into the unique approaches of the Global Medical Innovation program, highlighting the critical role of diverse healthcare settings in shaping future medtech innovators.

Key Timestamps:

• [00:01:00] Introduction of Dr. Matthew Wettergreen and his background.
• [00:03:30] Overview of the Global Medical Innovation program at Rice University.
• [00:07:45] Importance of contextual and global perspectives in medical device innovation.
• [00:14:00] Experiences and lessons learned from Costa Rica’s healthcare system.
• [00:22:15] Discussing out-of-context healthcare settings in Brownsville, Texas.
• [00:30:00] Navigating healthcare hierarchies and observer bias in medical device innovation.
• [00:45:00] Differences between student learning processes and typical industry practices.
• [00:55:20] Practical tips for companies to broaden their medtech innovation perspectives.
• [01:05:30] Final thoughts on the importance of diverse lenses in medtech innovation.

Quotes:

1. "Understanding healthcare from a 360-degree view is important because it helps you to understand why those specific practices are done." - Dr. Matthew Wettergreen
2. "Our goal is to prepare students to enter the medtech industry in a range of jobs by simulating professional practice in diverse contexts." - Dr. Matthew Wettergreen
3. "Recognize that you're wearing a lens and train yourself to try and take off that lens and put on a new one." - Dr. Matthew Wettergreen

Key Takeaways:

Latest MedTech Trends:

1. The significance of global and contextual perspectives in medical device innovation.
2. The rising role of telemedicine in reaching low-income and underserved populations.
3. The importance of functional, cost-effective solutions in global healthcare settings.

Practical Tips for MedTech Enthusiasts:

1. Engage in clinical needs-finding activities to better understand the healthcare environment.
2. Encourage facilitated discussions and case studies within your organization.
3. Explore and appreciate diverse healthcare systems to innovate effectively.

Questions Predicting Future Developments:

1. How will telemedicine evolve to cater to the needs of the lowest SES populations?
2. What are the potential impacts of integrating global healthcare perspectives in local innovations?
3. How can medtech companies better prepare their employees to understand upstream and downstream processes?

References:

• Rice University's Global Medical Innovation Program
• Pumani CPAP Device
• Dr. Matthew Wettergreen on LinkedIn
• Etienne Nichols LinkedIn

MedTech 101:

• Telemedicine: Remote diagnosis and treatment of patients

In this episode, host Etienne Nichols is joined by Mark DuVal, President and CEO of DuVal & Associates, and Kathy Herzog, Senior Regulatory, Quality, and Compliance Associate at DuVal & Associates. They delve into the recent FDA proposed rule for wound dressings, addressing the classification and regulatory impacts on medical device manufacturers. The discussion covers the historical context, the potential implications for the industry, and strategies for companies to navigate these changes.

• [00:00] - Introduction to the episode and guests
• [02:15] - Overview of Greenlight Guru's QMS software
• [04:30] - Introduction to the FDA's proposed rule on wound dressings
• [06:00] - Mark DuVal discusses the broad implications of the proposed rule
• [12:45] - Kathy Herzog explains the performance requirements and administrative record
• [22:00] - Discussion on industry response and potential litigation
• [30:30] - Impacts on existing and new products in the market
• [40:20] - Strategies for companies to navigate the proposed changes
• [50:00] - Broader implications for the FDA and potential future regulations
• [60:00] - Final thoughts and ways to stay informed

• "This proposed rule feels like a solution in search of a problem." - Mark DuVal
• "It's unsustainable that small wound dressing manufacturers would have to bear that burden on the back of an individual wound dressing." - Kathy Herzog
• "FDA's move to over-regulate well-settled product categories is deeply concerning." - Mark DuVal

MedTech Trends:

1. The FDA's proposed rule could significantly impact the classification and regulation of wound dressings.
2. There is substantial industry opposition to the proposed rule, with many companies and trade associations voicing their concerns.
3. The broader implications of the FDA's actions suggest a shift towards more aggressive regulatory measures.

Practical Tips:

1. Stay informed about regulatory changes and participate in comment periods to voice concerns.
2. Prepare for potential new testing and data requirements by reviewing current performance testing protocols.
3. Engage with industry groups and legal experts to understand the full impact of proposed regulations.

Future Developments:

1. How will the FDA address industry pushback and potential litigation against the proposed rule?
2. Will there be additional guidance from the FDA to help manufacturers navigate the new requirements?
3. What other product categories might the FDA target for reclassification in the near future?

• Greenlight Guru QMS Software
• FDA Proposed Ruling on Wound Dressings
• DuVal & Associates Client Alert on FDA Proposed Rule
• Alliance of Wound Care Stakeholders
• Washington Legal Foundation
• Connect with Etienne...

In this episode of the Global Medical Device Podcast, Etienne Nichols sits down with Dr. Gail Lebovic, an internationally recognized oncoplastic surgeon and innovative entrepreneur.

They delve into the evolving landscape of MedTech, focusing on the shift from traditional reimbursement models to direct-to-consumer strategies. Dr. Lebovic shares her journey of pioneering nasal health products during the COVID-19 pandemic, emphasizing the importance of flexibility and addressing real clinical needs. The conversation explores the broader implications for the future of healthcare, prevention, and patient empowerment.

• [02:15] – Introduction to Dr. Gail Lebovic and her background.
• [06:45] – Discussing the shift from traditional payer models to direct-to-consumer strategies.
• [12:30] – Challenges faced during the COVID-19 pandemic and pivoting strategies.
• [20:00] – The importance of flexibility in MedTech innovation.
• [30:10] – The significance of nasal health and hygiene.
• [40:25] – Going to market on Amazon and its impact on the business.
• [50:50] – Future trends in MedTech and women's healthcare.
• [01:05:15] – Advice for aspiring MedTech entrepreneurs.

• "People are smart, our patients are smart, and all of our patients are consumers." – Dr. Gail Lebovic
• "Healthcare is really not healthcare; it's really sick care." – Dr. Gail Lebovic

Key Insights:

1. The shift from traditional reimbursement models to direct-to-consumer strategies can enhance patient care and accessibility.
2. Prevention and self-care are becoming increasingly important in the healthcare landscape.
3. Innovation in MedTech requires flexibility, robust research, and addressing real clinical needs.

Practical Tips:

1. Stay open to changing strategies based on market demands and environmental factors.
2. Ensure your product stands out by maintaining high clinical standards, even in consumer markets.
3. Utilize platforms like Amazon to reach a broader audience while maintaining rigorous quality controls.

Future Questions:

1. What new preventive health products will emerge in the next five years?
2. How will the healthcare system adapt to increasing patient empowerment and self-care trends?

1. Greenlight Guru – For all-in-one QMS software designed specifically for the medical device industry. Visit Greenlight Guru.
2. Silicon Valley Innovations – Founded by Dr. Gail Lebovic, introducing anatomically directed drug delivery. Learn More.
3. Dr. Gail Lebovic on LinkedIn – Connect with Dr. Lebovic for more insights into MedTech innovations. Connect on LinkedIn.
4. Nasoclenz on Amazon - Check out how Silicon Valley Innovations is marketing their products direct-to-consumer on Amazon. Learn more.

Direct-to-Consumer (DTC) Strategy:

A direct-to-consumer (DTC) strategy involves marketing and selling products directly to consumers, bypassing traditional healthcare providers or payers. This approach can increase accessibility, reduce costs, and empower patients to take control of their...

In this episode, Etienne Nichols is joined by Shaherah Yancy, CEO of Research Lifecycle Solutions. They dive deep into the critical importance of developing robust clinical and regulatory strategies for MedTech companies. Shaherah shares her extensive experience in the field, providing practical advice on securing funding, ensuring market access, and achieving market adoption. They explore the nuances of clinical evidence, the significance of strategic planning, and the role of advisory panels in navigating the MedTech landscape.

• 00:00 - 03:00 Introduction and Sponsor Message
• 03:01 - 05:20 Introduction to Shaherah Yancy and her background
• 05:21 - 10:30 Importance of Clinical and Regulatory Strategies
• 10:31 - 17:15 Challenges of Securing Funding and Developing Strategy
• 17:16 - 25:45 Differences Between Market Access and Market Adoption
• 25:46 - 33:50 Developing Effective Clinical Plans for Market Adoption
• 33:51 - 39:40 Importance of Evidence and Study Design
• 39:41 - 48:00 Examples and Case Studies from Early Stage Companies
• 48:01 - 55:15 Endpoints for Market Adoption
• 55:16 - 01:02:30 Strategies for Novel Technologies
• 01:02:31 - 01:07:45 Final Advice and Contact Information

• "Market access is a milestone. Market adoption is the goal." - Shaherah Yancy
• "Understanding the problem you’re solving is crucial for your strategy." - Shaherah Yancy
• "Don’t be afraid of clinical evidence; it’s your key to success." - Shaherah Yancy

MedTech Trends:

1. Strategic Planning is Essential: Early and comprehensive planning for clinical and regulatory strategies can significantly enhance a company's chances of success.
2. Clinical Evidence is Critical: Collecting robust clinical data is vital for both market access and long-term market adoption.
3. Market Adoption Over Market Access: The ultimate goal should be market adoption, not just getting to market.

Practical Tips:

1. Form Advisory Panels: Engage with surgeons and clinical experts early to guide product development and market entry strategies.
2. Comprehensive Studies: Design studies that include both primary endpoints for regulatory approval and secondary endpoints for market adoption.
3. Prepare for Limited Market Releases: Use limited market releases to gather real-world evidence and refine products before a full launch.

• Research Lifecycle Solutions: Shaherah Yancy's company, specializing in clinical and regulatory strategies for MedTech. RLC Solutions
• Greenlight Guru Clinical: The sponsor of this episode, offering a platform for streamlining clinical trials. Greenlight Guru Clinical
• Etienne Nichols LinkedIn: Connect with Etienne on LinkedIn for more insights. Etienne Nichols LinkedIn

Clinical Evidence: Data collected from clinical trials and studies to demonstrate the safety and efficacy of a medical device.

510(k) Clearance: A premarket submission made to the FDA to demonstrate that the device to be marketed is at least as safe and effective as a legally...

In this episode of the Global Medical Device Podcast, host Etienne Nichols, along with part-time co-host Stephanie Hinton, dives into the art of clinical trial recruitment with Dr. Kelly Palmer, Assistant Professor at the University of Arizona. Dr. Palmer shares her extensive experience and innovative strategies for overcoming recruitment challenges, emphasizing the importance of community engagement, tailored approaches, and flexibility. The discussion highlights how to recruit diverse populations, manage logistical complexities, and ensure participant engagement, ultimately enhancing the success of clinical trials.

Key Timestamps:

• [00:02] – Introduction by Etienne Nichols
• [00:52] – Introduction of Dr. Kelly Palmer by Stephanie Hinton
• [03:15] – Kelly Palmer’s background and approach to recruitment
• [06:45] – Strategies for effective participant recruitment
• [12:30] – Building relationships with community organizations
• [18:00] – Overcoming practical challenges in clinical trials
• [26:45] – Using technology for data capture and improving efficiency
• [36:10] – Stories of recruitment challenges and solutions
• [45:00] – Key takeaways and advice for clinical trial professionals

Quotes:

• "Recruitment is not just about numbers; it's about building trust and relationships within the community." - Dr. Kelly Palmer
• "Think outside the box and always track your efforts to understand what works best." - Dr. Kelly Palmer
• "In research, you have to be flexible and ready to adapt to the needs of your participants." - Stephanie Hinton

Takeaways:

MedTech Trends:

1. Community engagement is crucial for successful recruitment in clinical trials.
2. Leveraging technology can streamline data capture and reduce errors.
3. Flexibility and adaptability are key to managing logistical challenges in research.

Practical Tips:

1. Develop strong relationships with community organizations to build trust and facilitate recruitment.
2. Implement electronic data capture systems to improve efficiency and accuracy.
3. Always have backup plans for logistics and be prepared to pivot quickly.

Future Predictions:

1. Increased use of AI and technology to enhance recruitment and data management.
2. Growing emphasis on diversity and inclusion in clinical trial populations.
3. Greater collaboration between researchers and community organizations.

References:

1. Greenlight Guru Clinical – Learn more about their all-in-one clinical development platform.
2. IU School of Medicine – Collaboration with community organizations for recruitment.
3. Dr. Kelly Palmer on LinkedIn
4. Stephanie Hinton on LinkedIn
5. Etienne Nichols on LinkedIn

MedTech 101:

Clinical Trial Recruitment: The process of enrolling participants into clinical trials, crucial for gathering data to test the efficacy and safety of new medical devices or treatments. Effective recruitment strategies ensure diverse and representative...

In this episode of the Global Medical Device Podcast, host Etienne Nichols talks with Mitch Robbins, founder of the Anthony Michael Group, about the evolving landscape of hiring and job seeking in the MedTech industry in 2024. They discuss strategies for both employers and job seekers, emphasizing the importance of preparation, effective communication, and proactive networking. Mitch shares actionable tips to enhance the interview experience and improve hiring outcomes, making this episode essential listening for anyone involved in MedTech recruitment.

Key Timestamps:

• [00:00] - Introduction and overview of the episode
• [03:15] - Mitch Robbins on the current state of the MedTech job market
• [07:30] - Importance of candidate experience in the hiring process
• [12:45] - Preparing for job interviews: Insights and tips
• [25:10] - Effective networking strategies for job seekers
• [35:00] - Onboarding new hires: Best practices
• [45:30] - Overcoming the challenges of layoffs and finding new opportunities
• [55:00] - Final thoughts and advice from Mitch Robbins

Quotes:

1. "The more value you demonstrate throughout the interview process, the more leverage you create for yourself." - Mitch Robbins
2. "Hiring is a team sport. It takes a team to court a candidate." - Mitch Robbins
3. "Always try to think above the line, like, how can I get to this person warmly?" - Mitch Robbins

Takeaways:

Key Insights about the Latest MedTech Trends:

1. The current job market has shifted to favor employers, making candidate experience crucial.
2. Networking and leveraging personal connections are more important than ever for job seekers.
3. Proactive follow-ups and personalized communication can significantly increase your chances of landing a job.

Practical Tips for Listeners Interested in MedTech:

1. Prepare thoroughly for interviews by researching the company and understanding their needs.
2. Utilize LinkedIn and other professional networks to connect with potential employers and peers.
3. Be proactive in your job search by reaching out directly to hiring managers and using creative approaches like video introductions.

Questions Predicting Future Developments in the Field:

1. How will the increasing reliance on remote work impact hiring practices in the MedTech industry?
2. What new technologies will emerge to assist with the hiring and onboarding process?
3. How will the balance of power between employers and job seekers continue to evolve in the next few years?

References:

1. Greenlight Guru - The game-changing solution for medical device companies looking to streamline their quality and clinical processes.
2. Anthony Michael Group - Mitch Robbins' executive search firm specializing in the MedTech industry.
3. Mitch Robbins on LinkedIn
4. Etienne Nichols on LinkedIn

MedTech 101:

For new listeners, here are some basic terms and concepts discussed in this episode:

• EQMS (Enterprise Quality Management Software): Software that helps manage quality processes within an organization.
• EDC (Electronic Data Capture): Systems used to collect clinical trial data electronically.
• Regulatory Submissions: Documentation required by regulatory bodies to approve new medical devices for...

In this episode of the Global Medical Device Podcast, host Etienne Nichols is joined by Jamie Bihary, a Medical Device Guru at Greenlight Guru. Jamie shares her journey from biomedical engineering to her current role, where she helps companies transition from legacy quality management systems (QMS) to cutting-edge electronic QMS (EQMS). They discuss the common challenges faced during these transitions, the importance of environmental monitoring in clean rooms, and practical advice for managing QMS implementations. Jamie also highlights the value of Greenlight Guru’s resources, including their robust partner network and support systems.

• 00:00 - 02:00 Introduction and Jamie Bihary’s background
• 02:01 - 05:30 A day in the life of a Medical Device Guru at Greenlight Guru
• 05:31 - 10:15 Common challenges faced by new MedTech companies
• 10:16 - 15:00 Jamie’s journey from biomedical engineering to Greenlight Guru
• 15:01 - 20:30 Implementing EQMS and document migration process
• 20:31 - 25:45 Importance of environmental monitoring in clean rooms
• 25:46 - 30:10 Transitioning from legacy systems to EQMS
• 30:11 - 35:00 The value of internal audits and giving/receiving feedback
• 35:01 - 40:15 Greenlight Guru’s partner and alliance network
• 40:16 - 45:00 Key advice for companies starting or transitioning QMS

• "Our system had done really well with past audits, so it was crucial that we made the transition smoothly and accurately." – Jamie Bihary
• "Everyone in your organization impacts product quality in some capacity." – Jamie Bihary

1. Transitioning from legacy QMS to EQMS can significantly streamline quality management processes and enhance efficiency.
2. Internal audits and open communication are vital for continuous improvement and compliance in the MedTech industry.

1. Establish a detailed implementation plan for QMS transitions to ensure a clear and documented process.
2. Utilize the resources and support offered by partners and consultants to manage workload and expertise gaps.
3. Regularly conduct internal audits and encourage a culture of feedback to identify and rectify potential issues early.

1. How can smaller MedTech companies best leverage partnerships to stay competitive?

• Greenlight Guru: Learn more about their EQMS solutions and support network.
• FDA Database: Reference for regulatory guidelines and compliance.
• LinkedIn Profile of Jamie Bihary: Connect with Jamie for more insights and support.

Quality Management System (QMS): A QMS is a formalized system that documents processes, procedures, and responsibilities for achieving quality policies and objectives. It helps coordinate and direct an organization's activities to meet customer and regulatory requirements and improve its effectiveness and efficiency on a continuous basis.

Electronic Quality Management System (EQMS): An EQMS is a digital version of a QMS, offering automated processes, real-time data access, and integration with other enterprise systems to enhance compliance, efficiency, and overall quality management.

• Poll: What is the biggest challenge you face when transitioning from a legacy QMS to an EQMS? Email us your answers at

In this episode of the Global Medical Device Podcast, host Etienne Nichols chats with Weronika Michaluk and Zach Markin from HTD Health about their journey to achieving ISO 13485 certification. The discussion covers the importance of gap analysis, the value of a compliant agile approach, and the benefits of using Greenlight Guru’s eQMS software. Listeners will gain valuable insights into maintaining compliance and continuous improvement in the MedTech industry, as well as practical advice for navigating ISO 13485 certification.

• 00:00 - 02:00 - Introduction by Etienne Nichols
• 02:00 - 05:30 - Introduction to HTD Health and their focus
• 05:30 - 10:45 - Discussion on the importance of ISO 13485 certification
• 10:45 - 14:30 - Steps and preparations for achieving ISO 13485 certification
• 14:30 - 20:00 - Benefits and features of using Greenlight Guru’s eQMS
• 20:00 - 25:00 - Challenges and changes faced during the certification process
• 25:00 - 30:00 - Practical tips for preparing for an ISO 13485 audit
• 30:00 - 35:00 - Continuous improvement and future goals for HTD Health
• 35:00 - 40:00 - Closing thoughts and advice from Weonika Michaluk and Zach Markin

1. Weronika Michaluk: "Do a proper gap analysis and also think whether you have enough knowledge internally... it will make your life easier to reach out to a partner or consultant."
2. Zach Markin: "In services, there’s not one ideal agile, but the right flavor of agile for the work that needs to be done."
3. Weronika Michaluk: "Using Greenlight Guru made our lives easier, especially in managing traceability and ensuring compliance."

1. Gap Analysis: Conduct a thorough gap analysis to understand current capabilities and areas needing improvement.
2. Internal Expertise: Ensure you have the necessary internal expertise or consult with experienced partners.
3. Continuous Improvement: Regularly update and improve your processes to maintain compliance and efficiency.

• ISO 13485 Certification: Learn about the ISO 13485 standard for medical devices
• Visit Greenlight Guru for eQMS software solutions
• HTD Health
• Weronika Michaluk on LinkedIn
• Zack Markin on LinkedIn
• Connect with Etienne Nichols on LinkedIn.

ISO 13485: An international standard that outlines the requirements for a quality management system specific to the medical device industry. It ensures that organizations consistently meet customer and regulatory requirements related to medical devices.

QMS (Quality Management System): A structured system of procedures and processes covering all aspects of design, manufacturing, and distribution to ensure products meet regulatory standards and customer expectations.

CAPA (Corrective and Preventive Action): A process within a QMS to investigate and correct the root causes of identified issues and prevent their recurrence.

What MedTech innovation are you most excited about?

Email your thoughts to

In this engaging episode of the Global Medical Device Podcast, host Etienne Nichols sits down with Ron Richard, a seasoned expert in the medical device industry with over 35 years of experience. The discussion delves into the essentials of bringing a medical device to market, from the inception of an idea to commercialization. Ron shares his journey, the importance of effective elevator pitches, the nuances of regulatory pathways, and practical tips for aspiring inventors. With insights on avoiding common pitfalls and strategies for securing funding, this episode is a treasure trove for anyone interested in MedTech innovations.

• [00:00] - Introduction and Ron Richard’s background
• [04:50] - Early successes in inventing and bringing products to market
• [10:30] - Validating ideas and market need
• [17:15] - Regulatory pathways: 510(k) vs. PMA
• [24:00] - Class I products and direct-to-consumer strategies
• [30:45] - Funding strategies: Family and friends, VC, and IPO
• [42:20] - Overcoming pitfalls and avoiding shiny object syndrome
• [49:10] - The importance of having a clear cap table
• [55:30] - The chasm: Making the leap from idea to market
• [01:01:45] - Final takeaways and advice for MedTech innovators

1. Ron Richard: “One of the biggest things I tell inventors is that in order for you to raise money, people have to trust you and like you. You have to share within 30 seconds what your product does and what problem it solves.”
2. Etienne Nichols: “Pioneers get shot, settlers get rich. You can be innovative with a 510(k) product by making evolutionary improvements.”
3. Ron Richard: “The road to success is always under construction. Be prepared for obstacles and have a plan to navigate through them.”

1. Elevator Pitch: Develop a concise and compelling elevator pitch that clearly communicates your product’s value.
2. Validate Early: Use focus groups and stakeholder interviews to validate your idea before heavily investing.
3. Funding Strategy: Start with family and friends for initial funding, then approach VCs once you have patents and prototypes.

1. Increased Scrutiny: Regulatory bodies like the FDA may become more stringent, requiring more comprehensive testing and validation.
2. Telemedicine Integration: Future medical devices will likely need to integrate telemedicine capabilities to stay competitive.
3. AI and Diagnostics: Artificial Intelligence will play a significant role in diagnostics and personalized medicine, offering new avenues for innovation.

1. Ron Richard's Book: "Someday is Today: Get Your Ideas Out of Your Coffee Cup and on the Market" - [Amazon Link]
2. Etienne Nichols' LinkedIn: Etienne Nichols on LinkedIn
3. Ron Richard’s Website: Inventing Starts Today

• Class I: Low risk, often exempt from premarket notification (510(k)).
• Class II: Moderate risk, typically requires 510(k) premarket notification.
• Class III: High risk, requires PMA (Premarket Approval) with extensive data.

• Poll: What MedTech innovation do you think will have the most significant impact in the next five years? (Options: AI-driven diagnostics, wearable health monitors, surgical robots)
• Share your thoughts with us at podcast@greenlight.guru

We’d...

In this episode of the Global Medical Device Podcast, host Etienne Nichols welcomes back Dr. Mike Drues to discuss the critical aspects of obtaining Institutional Review Board (IRB) approval and interacting with the FDA for medical device clinical trials. They explore the roles of IRBs, the difference between significant and non-significant risk devices, and share invaluable advice on mitigating risks associated with clinical trials. Whether you're a newcomer or a seasoned professional in the MedTech industry, this episode offers essential insights to ensure your clinical studies are compliant and efficient.

• 00:01:20 – Introduction to Dr. Mike Drues and his accolades.
• 00:05:30 – Explanation of IRBs and their role in clinical trials.
• 00:15:10 – Differences between traditional and commercial IRBs.
• 00:22:40 – Discussion on significant vs. non-significant risk devices.
• 00:32:00 – Importance of pre-submission meetings with the FDA.
• 00:44:15 – Steps to take when an IRB disapproves your clinical trial.
• 01:00:30 – Practical tips for choosing the right IRB for your study.

• "Most 510 devices do not need clinical data. But if you do, even for a non-significant risk device, vetting that with the FDA in advance is wise." – Dr. Mike Drues
• "You don't want to create a problem where none exists, but avoiding FDA consultation can lead to costly surprises later." – Dr. Mike Drues
• "The primary mission of an IRB is to ensure the safety of the patients at that institution." – Dr. Mike Drues

1. Understanding IRBs: IRBs are local entities responsible for the ethical oversight of clinical trials, ensuring patient safety and compliance.
2. Risk Classification: The classification of your device as significant or non-significant risk dictates whether FDA approval is needed for your clinical trial.
3. Strategic Pre-Submission: Engaging in a pre-submission meeting with the FDA can prevent costly delays and ensure your clinical trial meets all necessary endpoints.

1. IRB Shopping: If faced with an IRB denial, consider alternative institutions or commercial IRBs to avoid delays.
2. Comprehensive Submissions: Prepare thorough submissions for IRBs, including device descriptions, clinical trial protocols, and informed consent forms.
3. Physician Champions: Having a physician advocate at the institution can streamline the approval process and facilitate patient enrollment.

1. How will the evolving landscape of MedTech regulations impact the approval process for new devices?
2. What role will real-world evidence play in future clinical trials for medical devices?
3. How can smaller companies navigate the complexities of FDA and IRB requirements effectively?

• Etienne Nichols on LinkedIn
• Mike Drues on LinkedIn
• Greenlight Guru can help with Clinical Investigations
• Good Clinical Practices (GCP) regulations for IRBs

An Institutional Review Board (IRB) is a committee established to review and approve research involving human subjects. The primary purpose of an IRB is to ensure the ethical and safe treatment of participants in clinical trials.

An Investigational Device...

In this special episode of the Global Medical Device Podcast, Etienne Nichols switches roles from host to guest as Devon Campbell turns the tables to explore the invaluable lessons Etienne has learned from over 100 podcast episodes. Delve into key insights on product development, quality management, and the power of vulnerability and networking. Etienne shares practical tips and personal anecdotes that reveal the nuances of the MedTech industry, making this episode a treasure trove of knowledge for both new and seasoned professionals.

Key Timestamps:

• [02:15] - Introduction and Etienne’s journey to becoming a podcast host
• [12:30] - The importance of vulnerability and honesty in product development
• [22:45] - Balancing quality for audits versus operational benefits
• [30:10] - Human factors and usability in MedTech product development
• [37:55] - Simplifying quality management systems
• [45:00] - The mantra of learn, lead, and love in networking
• [54:20] - Encouraging emerging entrepreneurs to own their expertise and impact regulations

Quotes:

1. "The heart of the problem is the seed of the solution."
2. "Quality management documents should benefit your company first and be audit-ready second."
3. "Be genuinely curious. Assume the person in front of you knows something worth listening to."

Takeaways:

Key Insights on the Latest MedTech Trends:

1. Human factors and usability are often misunderstood but crucial in MedTech product development.
2. Quality management systems should be practical and beneficial for the company, not just for audits.
3. Networking is more than collecting business cards; it's about building meaningful connections.

Practical Tips for MedTech Professionals:

1. Be vulnerable and honest about the state of your projects.
2. Focus on solving the right problems and avoid over-engineering.
3. Create quality management documents that are easy to understand and useful for your team.

Questions Predicting Future Developments:

1. How will AI and machine learning shape the future of MedTech product development?
2. What emerging trends in usability and human factors will impact regulatory changes?
3. How can MedTech companies better prepare for cybersecurity challenges?

References:

• Greenlight Guru - Quality management software for medical devices.
• Etienne Nichols - LinkedIn
• Devon Campbell - LinkedIn
• Prodct LLC - Devon's advisory firm
• Fred Crosby’s Quality is Free - A book on quality management principles.

Beginner's Section: MedTech 101

• Quality Management System (QMS): The system that outlines the processes and procedures to ensure product quality.
• Human Factors and Usability: The study of how people interact with products to improve design and user experience.
• Regulatory Strategy: The plan for complying with regulations to bring a medical device to market.

Questions for the Audience:

• Poll: What do you think will be the most impactful MedTech advancement in the next five years? Email us your thoughts at

In this episode of the Global Medical Device Podcast, host Etienne Nichols engages with Howard Root, former CEO of Vascular Solutions and author of "Cardiac Arrest: Five Heart-Stopping Years as a CEO on the Fed’s Hit List," and Mark Duval, President and CEO of DuVal & Associates.

The episode delves into the harrowing experiences of navigating severe legal battles over off-label promotions, highlighting crucial insights into maintaining innovation while managing legal risks in the MedTech field. Additionally, Mark DuVal, a noted regulatory attorney, provides his expertise on the responsible corporate officer doctrine and its implications for industry executives.

• [00:00:15] - Introduction by Etienne Nichols.
• [00:01:30] - Howard Root's background and the origins of Vascular Solutions.
• [00:05:00] - Mark DuVal introduces Howard Root, detailing his legal battles.
• [00:10:00] - Howard Root discusses the intricacies of his federal indictment and the subsequent trial.
• [00:30:00] - Discussion on corporate responsibility and regulatory implications in the MedTech industry.
• [00:50:00] - Audience Q&A session with Howard Root and Mark DuVal.
• [01:10:00] - Closing remarks and takeaways.

• Howard Root: "We're not imposing rules at the bare legal minimum...we want to have a gray area. It’s why you drive 55 in a 60 zone."
• Mark DuVal: "Always be truthful, fairly balanced, and not misleading when discussing device applications."

Latest MedTech Trends:

1. Increased scrutiny on off-label promotions highlights the need for clear regulatory strategies.
2. Growing legal precedents emphasize the importance of corporate responsibility at all levels of operation.
3. The role of ethical practices in sustaining innovation within the MedTech industry.

Practical Tips for MedTech Professionals:

1. Ensure thorough understanding and compliance with FDA guidelines and local regulations.
2. Implement robust training and compliance programs for all staff, particularly in sales and marketing.
3. Engage experienced legal counsel to navigate complex regulatory landscapes.

Future Predictions in MedTech:

1. Enhanced regulatory frameworks to better define and manage off-label use.
2. Greater use of AI and data analytics to monitor compliance and ethical practices.
3. Increased advocacy for legislative changes to protect innovators from aggressive legal challenges.

• Howard Root's book, "Cardiac Arrest: Five Heart-Stopping Years as a CEO on the Fed’s Hit List"
• Mark DuVal on LinkedIn
• DuVal & Associates Client Alerts
• FDA guidelines on off-label promotions

In this episode, Lisa Van Ryn, a seasoned expert from Greenlight Guru, shares her extensive knowledge on the FDA’s Medical Device Reporting (MDR). We unpack the nuances of when and how to report incidents, the definition of serious injuries, and the importance of effective complaint management systems. Lisa provides practical advice on setting up robust reporting processes and explains how manufacturers can avoid common pitfalls.

Key Timestamps:

• [01:20] Introduction of Lisa Van Ryn and discussion on FDA's Medical Device Reporting
• [05:45] Lisa's transition from the restaurant industry to medical devices
• [10:30] What triggers a medical device report to the FDA?
• [15:25] Role-play on handling complaints and determining reportability
• [25:00] Detailed explanation of the decision tree for reporting
• [35:15] Differentiating between device malfunctions and serious injuries
• [40:10] Real-life examples and clarifying complex reporting scenarios
• [50:30] The repercussions of late reporting and the importance of timing
• [55:20] Wrapping up and resources for deeper understanding

Insightful Quotes:

• "Every complaint needs to be evaluated to determine if it is reportable under 21 CFRR Part 803." - Lisa Van Ryn
• "Having a beginner’s mindset but the heart of a teacher is essential in the medical device industry." - Etienne Nichols
• "If you’re not considering the feedback as important, whether it’s reportable or not, you are missing valuable data." - Lisa Van Ryn

Key Takeaways:

1. Understanding MDR: The importance of being thoroughly familiar with Medical Device Reporting guidelines to ensure proper reporting and compliance.
2. Setting Up Processes: Tips on setting up an effective complaint handling system to manage and report incidents correctly.
3. Common Pitfalls: Common issues manufacturers face and how to avoid them by implementing efficient and compliant processes.

References and Resources:

• Medical Device Reporting (MDR): How to Take Advantage of Your Electronic Records
• Lisa Van Ryn on LinkedIn
• Etienne Nichols on LinkedIn

Beginner’s Section: MedTech 101

• Medical Device Reporting (MDR): This refers to the regulatory process in which manufacturers are required to report certain types of incidents and malfunctions related to medical devices to the FDA.
• Serious Injury: A serious injury in the context of MDR is defined as an injury that is life-threatening, results in permanent impairment, or necessitates medical or surgical intervention to prevent permanent damage.
• Complaint Handling: The process by which manufacturers receive, review, and respond to customer complaints about the safety and quality of their medical devices.

Questions for the Audience:

• Poll: Do you believe current regulations on medical device reporting are sufficient for ensuring patient safety?

Feedback Request:

We value your thoughts! Please leave us a review on iTunes and share your feedback. Your suggestions help us improve and guide our future topics. Email your thoughts and topic suggestions to podcast@greenlight.guru.

Sponsors:

This episode is brought to you by Greenlight Guru, a leading platform that offers MedTech companies a...

In this insightful episode of the Global Medical Device Podcast, host Etienne Nichols delves into the journey of Dr. Lee Hunter, an orthopedic surgeon and innovator in elbow surgery devices. Dr. Hunter shares his experience from the conception of a simple yet effective surgical device through its development, struggles with initial licensing, and ultimate success in the market. The discussion highlights the importance of perseverance, the impact of regulatory insights, and the significant role of strategic innovation in enhancing patient outcomes.

• [00:45] - Introduction of Dr. Lee Hunter and his medical device journey.
• [05:30] - Challenges and breakthroughs in designing elbow surgery devices.
• [14:20] - The licensing journey and learning from initial failures.
• [22:50] - Insights into the current medical device market and innovations.
• [35:40] - Discussion on the importance of simplicity and efficiency in medical devices.
• [48:15] - Future directions in MedTech and advice for new innovators.

• "Sometimes the simplest solutions are the hardest to find but the most effective once implemented." - Lee Hunter

1. Innovation in MedTech: Dr. Hunter's journey emphasizes that true innovation often stems from a deep understanding of specific medical needs rather than broad technological applications.
2. Challenges and Resilience: Early failures are often stepping stones to success, highlighting the importance of resilience and adaptability in the medical device industry.
3. Future of MedTech: The potential for simpler, more effective devices that streamline medical procedures and improve outcomes is vast, urging current and future innovators to focus on practical and impactful innovations.

In today's episode, terms like "elbow arthroscopy" and "lateral decubitus position" were discussed. Elbow arthroscopy involves a minimally invasive surgical procedure on the elbow using an arthroscope, while lateral decubitus position refers to the patient lying on their side, which is common during such surgeries.

Did this episode on medical device innovation resonate with you? We would love to hear your thoughts and feedback. Leave us a review on iTunes and share your views on the future of MedTech innovations! For suggestions on future topics, please email us at podcast@greenlight.guru

• Hunter Medical Devices
• Dr. Lee hunter on LinkedIn
• Tennessee Orthopedic Alliance
• Etienne Nichols on LinkedIn

This episode is brought to you by Greenlight Guru, a leading company in medical device consulting. Their expertise and services align seamlessly with the needs of the MedTech community, helping bring revolutionary devices to the market efficiently. Check out their special offers for podcast listeners today!

In this episode, host Etienne Nichols speaks with Christine Luk, Associate Regulatory Affairs Manager at Proxima, about her journey through the medical device sector. From her academic beginnings in biochemistry and biomedical engineering to founding a startup and navigating FDA regulatory pathways, Christine offers a wealth of knowledge. The discussion delves into the intricacies of working with regulatory consultants, the significance of FDA interactions, and practical tips for medical device startups aiming to maneuver through regulatory challenges successfully.

• [00:02:30] Christine's journey from biochemistry to medical device innovation
• [00:15:00] Insights on starting a medtech startup and the early failures
• [00:30:45] Effective collaboration with regulatory consultants
• [00:45:10] Handling FDA interactions and strategic submissions
• [01:00:20] Advice for medtech startups on navigating regulatory environments

• "You're pitching all these awesome capabilities of your device, meanwhile on the FDA side, we're asking, who are you most like?" – Christine Luk
• "Every meeting is money. Making sure everybody is aligned and on the same page is crucial when dealing with consultants." – Christine Luk

• Engage with local medtech communities and resources, such as accelerators or innovation hubs.
• Early interactions with the FDA can significantly influence your device’s regulatory pathway.
• Thorough documentation and clear communication with consultants are essential for effective project management.

• Texas Medical Center Innovation Institute
• Proxima Clinical Research
• Christine Luk on LinkedIn
• Etienne Nichols on LinkedIn

Feedback is crucial! Please email us your thoughts on this episode and suggestions for future topics at podcast@greenlight.guru

Don’t forget to leave us a review on iTunes!

This episode is proudly sponsored by Greenlight Guru, a global leader in MedTech-specific software solutions. Whether you're in the clinical trial phase or ensuring compliance with quality standards, Greenlight Guru offers tailored solutions to streamline your processes. Their software is designed specifically for the medical device industry, helping companies accelerate their product development with confidence and compliance. Learn more about how Greenlight Guru can illuminate your path to market success by visiting their website at Greenlight Guru. Equip your team with the tools to simplify quality management and keep your focus on innovation and patient safety.

In this episode of the Global Medical Device Podcast, host Etienne Nichols engages with Helene Quie, an expert in medical device regulations and clinical investigations. They delve into the dual aspects of risk management: ensuring product safety and the procedural risks associated with clinical protocols. Helene emphasizes the importance of a measurable, data-driven approach to balancing risks and benefits and discusses the challenges companies face in aligning their clinical investigations with stringent regulatory standards.

• 00:00:45 - Introduction to Helene Quie and the topic of risk management in clinical investigations.
• 00:05:22 - Discussing the first leg of risk management: managing residual risks in product safety.
• 00:17:50 - Exploring the second leg: the procedural risks in clinical protocols.
• 00:28:30 - Challenges of enrollment and protocol design.
• 00:35:45 - The impact of regulatory changes on clinical investigations.
• 00:49:10 - Addressing the integration of artificial intelligence in medical devices.
• 01:03:15 - Closing thoughts and call to action from Helene Quie.

• "It's not just about managing risks; it's about ensuring that the benefits are powerful enough to justify those risks." - Helene Quie
• "Every clinical investigation introduces its own set of risks, not just from the product but from the study protocol itself." - Helene Quie
• "We must not only wear different glasses to see through the regulatory and practical aspects but also validate our views with the actual stakeholders involved." - Helene Quie

1. Insights on MedTech Trends:

• The increasing importance of data in justifying product safety and efficacy.
• The shift from intuition-based to evidence-based risk assessment.
• Regulatory bodies are placing greater emphasis on comprehensive clinical evaluations.

2. Practical Tips for MedTech Professionals:

• Ensure that risk assessments are detailed and backed by solid data.
• Consider the practical aspects of clinical trial protocols from multiple perspectives.
• Stay updated on regulatory changes to adapt protocols and product development effectively.

3. Future Predictions in MedTech:

• Enhanced scrutiny and requirements for clinical investigations.
• Greater integration of AI and digital tools in medical devices.
• Potential regulatory adaptations to accommodate innovations.

• Helene Quie on LinkedIn
• Etienne Nichols on LinkedIn
• QMED Consulting
• Questions to ask for Clinical Preparation
• EUMDR and MDD Comparisons: Insights into how regulatory frameworks have evolved and their impact on medical device development.

For new listeners, this episode touches upon fundamental concepts like residual risk, clinical protocol, and risk-benefit assessment in the context of medical device clinical investigations. Understanding these terms is crucial for grasping the detailed discussions of the episode.

• Discussion Question: "What are your expectations for the future of healthcare with advancements in MedTech?"
• Feedback Request:...

In this episode of the Global Medical Device Podcast, host Etienne Nichols delves into the intricate world of in vitro diagnostics (IVDs) with Christie Hughes, a principal consultant and IVD expert at Qserve Group. With over 25 years of experience, Christie shares her extensive knowledge, discussing the nuances of IVDs, regulatory landscapes, and practical insights for professionals transitioning into or within the IVD sector.

Key Timestamps:

• [00:00:45] - Christie Hughes's introduction and background in IVDs
• [00:03:30] - Discussion on the regulatory challenges and trends in 2023
• [00:15:22] - Differences between IVDs and other medical devices in terms of regulatory and operational frameworks
• [00:25:50] - Impact of regulatory changes on labs and manufacturers
• [00:40:10] - Detailed exploration of user needs and design controls in IVD development
• [00:52:00] - Advice for medical device professionals entering the IVD space

Notable Quotes:

• "Understanding the user—whether a lab technician or a layperson—is critical in IVD development to ensure safety and effectiveness." - Christie Hughes

Key Takeaways:

1. Trends in MedTech: The regulatory environment for IVDs is rapidly evolving, with increased scrutiny and changes in compliance requirements globally.
2. Practical Tips: For those entering the IVD field, familiarize yourself with FDA decision summaries and EUA documentation to understand current regulatory expectations.
3. Future Predictions: Expect continued integration of IVDs with digital health technologies, raising both opportunities and regulatory complexities.

References and Resources:

• FDA decision summaries for recent IVD clearances
• European In Vitro Diagnostic Regulation (IVDR) updates
• CDRH Learn
• FDA Proposed Rule for LDTs
• Episode on LDTs with Shannon Bennett
• Christie Hughes on LinkedIn
• Etienne Nichols on LinkedIn

MedTech 101:

• In Vitro Diagnostic (IVD) Devices: Tools that analyze human samples (like blood or tissue) outside the body, used to diagnose diseases, conditions, or to monitor a person’s overall health.

Audience Interaction:

• Discussion Question: "How do you envision IVDs changing everyday healthcare practices in the future?"

Call for Feedback:

Love this episode? Leave us a review on iTunes and share your thoughts. Feedback drives our growth and allows us to improve. Reach out directly via email at podcast@greenlight.guru with your suggestions for future topics.

Special Thanks to Our Sponsor:

This episode is brought to you by Greenlight Guru, a quality management system and electronic data capture software designed...

In this episode of the Global Medical Device Podcast, Etienne Nichols engages with Sara Adams to discuss Quality Management Systems (QMS) in the medical device industry. The discussion unveils the complexities and common misconceptions surrounding QMS, drawing an intriguing analogy between building a QMS and crafting sourdough bread. Sara shares her extensive experience with FDA inspections and audits, emphasizing the essential, tailored approach needed for effective quality management.

This episode is brought to you by Cleio Medical Device Design. Discover how Cleio can transform your medical device concepts into market-ready products at cleio.com.

• [02:15] - Sara recounts her experiences with FDA inspections.
• [05:30] - Etienne introduces the sponsor and the episode’s focus on QMS.
• [12:00] - Sara explains what a QMS is and is not, breaking down the layers of quality control.
• [19:45] - Discussion on the practical steps to build and customize a QMS.
• [34:10] - Sara’s sourdough analogy to illustrate the process of developing a robust QMS.
• [48:55] - Examples of how different QMS systems can meet specific regulatory requirements.
• [1:02:30] - Closing thoughts on keeping the patient in mind when building a QMS.

• "You can't buy a QMS off the shelf; it's like trying to bake sourdough bread without understanding the process or the ingredients." – Sara Adams
• "The patient should be the focus of everything we do in the medical device industry." – Sara Adams

1. Increasing regulatory scrutiny on how QMS are implemented.
2. More companies are moving from paper-based to electronic QMS for better compliance and efficiency.
3. Growing emphasis on customizing QMS components to fit specific medical device regulatory needs.

1. Understand the components of your QMS and ensure they align with regulatory requirements.
2. Regularly review and update your QMS to adapt to new regulations and technologies.
3. Consider electronic solutions for better traceability and compliance.

1. What are the potential impacts of global regulatory harmonization on QMS?
2. How can startups efficiently implement a compliant QMS with limited resources?

• FDA Quality System Regulation (21 CFR Part 820)
• ISO 13485 standards for medical devices

• Poll: Do you believe that advances in electronic QMS will significantly reduce compliance issues in the next 5 years?

Enjoy this episode? Leave us a review on iTunes and suggest topics you’d like to hear about in future episodes. Email us your feedback and ideas at podcast@greenlight.guru

1. Follow Etienne on LinkedIn: Etienne Nichols
2. Follow Sara on LinkedIn: Sara Adams

Join us next time for more insights and expert advice in the medical device industry!

This episode of the Global Medical Device Podcast features a compelling conversation with Perry Parendo, a seasoned expert in product development and project management within the MedTech sector. Host Etienne Nichols and Perry delve into the challenges and opportunities facing medical device development, emphasizing the critical role of agile practices, risk management, and the necessity for a patient-focused approach. The discussion sheds light on how companies can navigate regulatory landscapes, manage project risks, and drive innovation to enhance patient care.

Key Timestamps:

• 00:00:15 - Introduction of Perry Parendo and the episode's focus
• 00:03:50 - Discussing the challenges of MedTech product development and regulatory hurdles
• 00:12:20 - Agile methodologies vs. traditional project management in MedTech
• 00:22:35 - The importance of risk management and Monte Carlo simulation in project planning
• 00:34:10 - Perry's perspective on innovation, compliance, and balancing project priorities
• 00:45:55 - Strategies for efficient and effective product development processes

Quotes:

• "We're so focused from a compliance point of view on patient and health risk, we're not focused on project risk. And when I worked in the defense industry, we were hugely focused on project risk," Perry Parendo
• "There's waterfall, there's agile, there's Toyota, there's set based design, and there's APQP in the automotive industry. They're all a blend. There's no organization that's doing purely the theoretical of any one of those processes," Perry Parendo

Takeaways

Insights on MedTech Trends:

1. The convergence of agile and traditional methodologies tailored to MedTech's unique demands.
2. The rising importance of advanced risk management techniques, like Monte Carlo simulations, in navigating project uncertainties.
3. A call for innovation that transcends regulatory compliance to genuinely benefit patient care.

Practical Tips for Listeners:

1. Adopt a flexible approach to project management by integrating various methodologies based on project needs.
2. Prioritize risk management early in the development process to foresee and mitigate potential challenges.
3. Always align product development objectives with the ultimate goal of improving patient outcomes.

Questions for Future Developments:

1. How will evolving regulatory standards shape the next generation of medical devices?
2. What role will patient feedback play in the design and development of future MedTech innovations?
3. Can MedTech sustain its pace of innovation while ensuring safety and compliance?

References:

• Perry Parendo on LinkedIn
• Etienne Nichols on LinkedIn
• Behavioral Grooves podcast with Annie Duke - Thinking in Bets
• Book - Someday is Today, Ron Richard
• Youtube video - the Heartbeat of New Product Development
• Quality Culture for Product Design Success

In this episode of the Global Medical Device Podcast, host Etienne Nichols sits down with Kim Kaplan from ISACA at the MD&M West trade show in Anaheim, California, to discuss the pivotal Voluntary Improvement Program (VIP). This conversation sheds light on how the program, stemming from FDA’s Case for Quality initiative, utilizes the Capability Maturity Model Integration (CMMI) to push medical device companies beyond compliance, towards excellence. Kaplan elucidates the history of VIP, its benefits, and how it aligns with the FDA’s vision for a more innovative and quality-focused MedTech industry.

• [00:00:30] Introduction of Kim Kaplan and the Voluntary Improvement Program
• [00:05:00] Explanation of CMMI and its adoption in the medical device industry
• [00:15:45] Distinctions between CMMI and other quality methodologies
• [00:25:30] In-depth discussion on the specifics and benefits of the Voluntary Improvement Program
• [00:40:00] How companies can implement change based on VIP insights
• [00:50:00] FDA’s perspective and regulatory opportunities tied to VIP participation

• “Organizations that are compliant aren't necessarily avoiding the types and numbers of issues faced by non-compliant ones.” - Kim Kaplan
• “CMMI focuses on the 'what' to do rather than the 'how,' allowing for a framework that compliments existing processes.” - Kim Kaplan
• “The Voluntary Improvement Program isn't just about compliance; it's about embracing continuous improvement as a culture.” - Kim Kaplan

1. Understanding VIP: The program aims to elevate quality and operational efficiency through a collaboration involving FDA, MDIC, industry stakeholders, and ISACA.
2. CMMI’s Role: CMMI’s flexible, globally adopted framework helps MedTech companies identify and implement best practices in product development and project management.
3. Benefits of Participation: Beyond improving quality, VIP participation can streamline regulatory processes, fostering quicker innovation and market access.

1. Engage with CMMI: Consider how CMMI’s framework could complement your company’s existing quality and project management processes.
2. Explore VIP: Assess your organization's readiness and potential benefits from enrolling in the Voluntary Improvement Program.
3. Continuous Improvement: Embrace continuous improvement, not just for compliance, but as a cornerstone of your company culture.

1. How will the integration of AI and digital health technologies impact the criteria for CMMI and VIP?
2. In what ways might the Voluntary Improvement Program evolve to further incentivize innovation in MedTech?
3. How will FDA’s regulatory framework adapt to the rapid advancements in medical device technologies?

• Etienne Nichols on LinkedIn
• Kim Kaplan on LinkedIn
• FDA’s Final Guidance on the Voluntary Improvement Program
• ISACA's overview of FDAs Voluntary Improvement Program (VIP)
• Regulatory opportunities of the...

In this episode of the Global Medical Device Podcast, host Etienne Nichols is joined by Gary Saner, a seasoned expert in medical device Unique Device Identification (UDI) and regulatory compliance. They embark on a comprehensive exploration of the ever-evolving landscape of UDI requirements, shedding light on crucial deadlines, common pitfalls, and strategic insights for achieving global compliance. From the intricacies of European UDI requirements to the specifics of implementing UDI systems in markets like Australia and beyond, this episode is a treasure trove of actionable insider knowledge for medical device professionals navigating the complexities of UDI compliance.

• "UDI has this ongoing life connected to it...it just doesn't seem to end. Once you do it, you're not done; you have to keep opening those books and making changes." - Gary Saner

1. Increasing global adoption of UDI requirements signifies a move towards standardized device identification for enhanced patient safety.
2. The push towards digital transformation in regulatory compliance highlights the industry's shift towards efficiency and data accuracy.
3. The growing complexity of global UDI regulations challenges manufacturers to adopt flexible and scalable solutions for compliance.

1. Start early with your UDI compliance strategy to accommodate the evolving nature of global regulations.
2. Engage with experts and consider leveraging technology solutions like ReTech for streamlined compliance processes.
3. Stay informed about regulatory changes in key markets to ensure continuous compliance and market access.

1. Will AI and machine learning play a more significant role in automating UDI compliance processes?
2. How will the expansion of UDI requirements into emerging markets affect global medical device distribution?
3. Can we expect a universal standard for UDI compliance to emerge, simplifying global regulatory landscapes?

• Gary Saner on LinkedIn
• Etienne Nichols on LinkedIn
• The Ultimate Guide for UDI
• ReedTech's UDI Compliance Solution

For new listeners, UDI (Unique Device Identification) is a system used by regulatory authorities to identify and track medical devices through their distribution and use. It's a crucial component of medical device regulation, ensuring the safety, efficacy, and traceability of devices.

• Poll: "What do you believe is the biggest challenge in achieving global UDI compliance?"
• Discussion Question: "How do you foresee the advancements in MedTech impacting healthcare delivery in the next decade?"

We value your feedback and ideas for future episodes. Please email us at podcast@greenlight.guru with your suggestions and thoughts.

This episode is brought to you by Greenlight Guru, the MedTech industry's leading solution for product development and compliance. Discover how Greenlight Guru can accelerate your product's journey to market by visiting www.greenlight.guru

In this episode of the Global Medical Device Podcast, host Etienne Nichols delves into the world of medical device quality and reliability with expert guest Kevin Becker. They explore the nuanced challenges of ethical decision-making in the MedTech industry, the complexities of accelerated testing, and the continuous quest for quality improvement. Becker, author of "Quality Myths and Lessons Learned," shares his insights from the second edition of his book, emphasizing the importance of ethics, the intricacies of statistical models, and the practical aspects of quality management in medical devices.

Key Timestamps:

• [00:00:00] Introduction to Kevin Becker and the topic of the episode
• [00:05:20] Discussion on the new chapter about ethics in Becker's book
• [00:10:35] Insights into accelerated testing and its application in medical devices
• [00:15:50] Kevin Becker's five levels of knowledge and its relevance to MedTech professionals
• [00:20:45] The significance of standing up for what's right in quality and regulatory matters
• [00:25:30] Real-life examples of complex problem-solving in medical device engineering
• [00:30:55] Final thoughts and advice from Kevin Becker for MedTech professionals

Quotes:

1. "The first level of knowledge is you don't have a clue... The third level is you know enough to be effective, which is where we all want to be." - Kevin Becker
2. "All models are wrong; some models are useful." - Quoted by Kevin Becker, highlighting the pragmatic approach in engineering and quality assurance.
3. "Do something, do anything. If it's wrong, we'll learn from it. Just do something." - Kevin Becker's advice to overcome analysis paralysis in product development.

Takeaways:

• Latest MedTech Trends: The episode underscores the critical role of ethics in the rapidly evolving MedTech industry, where technological advancements and moral responsibilities intersect.
• Practical Tips: Listeners gain practical insights into the importance of rigorous testing, continuous learning, and ethical decision-making in ensuring the quality and reliability of medical devices.
• Future Predictions: The discussion hints at the increasing significance of statistical models and accelerated testing in predicting and enhancing the longevity and efficacy of medical devices.

References:

• Quality Myths and Lessons Learned Part I: https://www.greenlight.guru/blog/quality-myths-and-lessons-learned
• Connect with Kevin Becker on LinkedIn: https://www.linkedin.com/in/kevin-becker-48627014/
• Kevin Becker's book "Quality Myths and Lessons Learned" (Second Edition) offers a deeper dive into the topics discussed, with a focus on ethics, quality management, and statistical methods in the medical device industry.
• Connect with Etienne Nichols on LinkedIn: https://www.linkedin.com/in/etiennenichols/

Questions for the Audience:

• Poll: "What do you believe is the most significant ethical challenge facing the MedTech industry...

In this episode of the Global Medical Device Podcast, host Etienne Nichols dives into the art of pitching to medical device investors with Blythe Karow, COO at Neurogeneces. Blythe shares her wealth of experience, from her early days as a marketer to leading significant product launches and achieving FDA breakthrough designations. The conversation revolves around crafting compelling pitches, understanding investor expectations, and navigating the challenges of presenting complex medical technologies to diverse audiences.

• [00:00:45] - Introduction to Blythe Karow and her background in MedTech.
• [00:03:22] - Insights into the dynamics of pitching to investors and adapting to different audiences.
• [00:10:15] - Discussion on the evolution of Blythe's pitching strategies over her career.
• [00:15:30] - Blythe's experience with gender dynamics in pitching and advice for female entrepreneurs.
• [00:20:45] - The importance of team presentation and handling expert critiques during pitches.
• [00:25:30] - Blythe's memorable pitch experiences and the impact of audience engagement.
• [00:30:00] - Tips for early-stage startups and resources for pitch preparation.
• [00:35:25] - Closing thoughts and where to connect with Blythe Karow.

• "You want to start with a problem, you want that problem to be in the voice of who would pay for it." - Blythe Karow
• "It's like dating, and you're going to find people you click with and people you don't click with." - Blythe Karow on finding the right investors.
• "Anyone can pitch. You just have to practice." - Blythe Karow

1. The convergence of digital health and traditional medical devices.
2. The rising importance of FDA breakthrough designations for startups.
3. The shift towards patient-centered design in medical devices.

1. Understand your audience before crafting your pitch.
2. Practice your pitch extensively to refine your message and delivery.
3. Build a cohesive team presentation to demonstrate unity and competence.

• Neurogeneces, Blythe's current venture in brain health wellness.
• Evren Technologies pitch video
• Medtech Innovator
• Blythe Karow on LinkedIn
• Etienne Nichols LinkedIn
• Springboard Digital Health Innovation Program

We value your feedback and suggestions for future episodes. Share your thoughts and ideas by leaving a review on iTunes or emailing podcast@greenlight.guru

This episode is brought to you by Greenlight Guru, a MedTech Suite designed to accelerate product development while ensuring regulatory compliance. Learn more at Greenlight Guru.

In this episode of the Global Medical Device Podcast, Etienne Nichols is joined by Kavetha Ram, a seasoned expert in health and pharmaceutical sciences and the regulatory department leader at Spectra Medical Devices. Together, they delve into how new regulatory affairs professionals can get started in a career of medical device regulations and the shifting field of MedTech. The discussion offers a roadmap for professionals to navigate and thrive amidst these shifts. The episode is a treasure trove of knowledge for anyone looking to stay ahead in the MedTech realm.

Key Timestamps:

• [00:00:30] Introduction to Kavetha Ram and the episode's focus
• [00:05:15] Discussion on the challenges and opportunities of new regulations
• [00:10:40] Insights into the importance of confidence and adaptability in the regulatory field
• [00:15:20] Kavetha's journey and advice for emerging professionals
• [00:25:00] The role of innovation and collaboration in MedTech advancements
• [00:35:10] Strategies for professionals to stay relevant and proactive

Quotes:

• "Regulations are not just hurdles; they are stepping stones to innovation and safety in MedTech." - Kavetha Ram
• "Embracing change in regulations is not an option but a necessity for MedTech's future." - Etienne Nichols
• "Diversity in teams isn't just about varied backgrounds; it's about unlocking unique perspectives that drive innovation." - Kavetha Ram

Key Takeaways:

Insights into MedTech Trends:

1. Regulatory changes are both a challenge and an opportunity for innovation.

Practical Tips for MedTech Enthusiasts:

1. Stay updated with regulatory changes and understand their implications.
2. Engage in continuous learning and skill development.
3. Foster collaboration across disciplines to enhance innovation.

References:

• Kavetha Ram's LinkedIn Profile
• Etienne Nichols' LinkedIn Profile
• Greenlight Guru

Questions for the Audience:

• "What advice do you have for budding Regulatory Affairs professionals?"

Reach out to us and let us know what you thought of the episode at podcast@greenlight.guru

Also, if you enjoyed this episode, please leave us a review on iTunes!

Sponsors:

This episode is brought to you by Greenlight Guru, the only quality management software designed specifically for the medical device industry. Greenlight Guru's platform streamlines product development and compliance, making the process more efficient and less risky. Discover how Greenlight Guru can accelerate your product development at www.greenlight.guru.

In this episode, Etienne Nichols and guest Ashkon Rasooli explore the transformative impact of AI in the medical device industry. From AI-driven diagnostics and wearable health monitors to the future of surgical robots, they delve into how these technologies are reshaping healthcare.

The discussion also touches on the challenges and opportunities in validating and regulating AI within MedTech, highlighting real-world applications and predicting future trends.

"Validation of AI tools in MedTech requires a staged adoption to build confidence due to the inherent uncertainty in AI outcomes." - Ashkon Rasooli

• 00:00 - Introduction to AI in MedTech
• 05:15 - Discussing AI's deterministic vs. statistical nature
• 12:30 - AI in diagnostics: Radiology, Cardiology, and Neurology
• 20:45 - Wearable health monitors and patient-driven health data
• 28:10 - The role of AI in medical device operations and manufacturing
• 35:00 - AI at the point of care: Enhancing patient and clinician experience
• 42:15 - Regulatory challenges and the future of AI in healthcare

Key Takeaways:

1. Latest MedTech Trends:

• The integration of AI in diagnostics is growing, particularly in radiology, cardiology, and neurology, aiding in more accurate and quicker diagnoses.
• Wearable health monitors are empowering patients to take control of their health data, leading to personalized healthcare solutions.

2. Practical Tips for MedTech Enthusiasts:

• Stay informed about the latest AI advancements and regulatory guidelines to leverage AI effectively in MedTech.
• Consider the ethical implications and ensure bias mitigation in AI model training and deployment.

3. Predictions for the Future:

• Increased adoption of AI across various healthcare sectors, including surgery and patient care management.
• Evolution of regulatory frameworks to better accommodate and oversee AI-driven medical devices.

References:

• Ashkon Rasooli on LinkedIn
• ashkon@engeniussolutions.com
• Engenius Solutions
• AFDO/RAPS Working Group
• Etienne Nichols on LinkedIn

Sponsors:

This episode is brought to you by Greenlight Guru, a comprehensive solution designed to streamline MedTech product development and ensure regulatory compliance. Discover how Greenlight Guru can accelerate your projects at www.greenlight.guru

Share your thoughts and questions with us at podcast@greenlight.guru

In this episode, we delve into the complexities and essentials of quality and regulatory roles in the medical device industry. Our esteemed guest, Jennifer Mascioli-Tudor, CEO and founder of JMT Compliance Consulting, shares her wealth of experience from top MedTech companies, underscoring the importance of proactive quality management, project management skills, and the ability to influence and communicate within organizations.

• [00:00:50] Introduction to Jennifer Mascioli-Tudor and her extensive background in the MedTech industry.
• [00:03:30] Jennifer's origin story in quality and regulatory roles.
• [00:07:15] The pivotal learning moments in quality management and regulatory affairs.
• [00:10:45] Strategies for influencing business leaders and the importance of storytelling in quality and regulatory roles.
• [00:16:30] The significance of human factors in product design and learning from end-user feedback.
• [00:21:50] Project management skills for quality and regulatory professionals.
• [00:25:20] The concept of 'design freeze' in the MedTech space and its impact on product development.
• [00:29:55] Jennifer's insights on agility and adaptability in building a quality management system.

• "A really good quality and regulatory professional needs to have really good project management skills." - Jennifer Mascioli-Tudor
• "It's not just about the design and about the product. It's about everything ancillary that feeds into that finished medical device." - Jennifer Mascioli-Tudor

1. An emphasis on proactive quality management to ensure patient safety and product efficacy.
2. The rising importance of human factors and user-centered design in medical device development.
3. The shift towards integrating software and digital solutions in medical devices.

1. Quality and regulatory professionals should hone their project management skills.
2. Communication and storytelling are key in influencing business decisions and leadership.
3. Always present solutions and alternatives when addressing compliance challenges.

• JMT Compliance Consulting
• Jennifer Mascioli-Tudor on LinkedIn
• Etienne Nichols on LinkedIn
• Greenlight Guru’s platform for Quality Management & Clinical Investigations

• Discussion: "How do you envision MedTech changing the landscape of healthcare in the next decade?"

• Love the episode? Have suggestions or topics you’d like to hear about? Email us at podcast@greenlight.guru and leave a review on iTunes!

This episode is brought to you by Greenlight Guru, the only quality management software designed specifically for the medical device industry. Streamline your process and foster innovation with Greenlight Guru’s intuitive platform!

In a today's conversation on the Global Medical Device Podcast, host Etienne Nichols engages with Dr. Maria Nyakern on the burgeoning integration of AI in medical devices. They delve into the European AI Act, discussing its impact on innovation and the critical role of trustworthy systems in clinical research. The episode also touches upon the challenges and opportunities AI presents in MedTech, from data integrity to job displacement, and the human-centric approach to technology.

Key Timestamps:

• [00:00:00] Introduction to the podcast and topic of AI in medical devices
• [00:03:25] Greenlight Guru's streamlined product development for MedTech
• [00:05:15] Dr. Maria Nyakern's background and entrance into AI
• [00:07:30] Discussion on the European AI Act and its significance
• [00:13:45] Comparison of US and European approaches to AI regulation
• [00:18:55] The intersection of MedTech experience and AI governance
• [00:23:10] The importance of data quality and integrity in AI-driven clinical research
• [00:29:00] The human aspect in AI development and clinical trials
• [00:35:10] Ethical considerations and the future of AI in MedTech

Quotes:

• "AI systems...will be more cost-effective and less of a hurdle for companies to generate data sets for subsets of patients." - Maria Nyakern
• "Trustworthy AI systems must be worthy of humans." - Maria Nyakern
• "Embrace innovation with Greenlight Guru." - Etienne Nichols

Takeaways:

Latest MedTech Trends:

1. Increased integration of AI in clinical research.
2. The rise of wearable health monitors.
3. Advancements in surgical robotics technology.

Practical Tips:

1. Stay updated on AI regulations.
2. Invest in trustworthy AI systems.
3. Leverage AI for cost-effective data generation.

Future Predictions:

1. AI will play a larger role in personalized medicine.
2. There will be a push for global AI data sharing.
3. Expect AI to drive faster, more accurate diagnostics.

References:

• European AI Act
• US Executive Order on AI
• Maria Nyakern on LinkedIn
• Etienne Nichols on LinkedIn

Questions for the Audience:

• Which AI-driven MedTech advancement excites you the most, and why?
• How do you envision healthcare changing in the next decade with the rise of MedTech innovations?"

We value your thoughts - if you enjoyed this episode, would like to give feedback, or have suggestions for future episodes, please email us at podcast@greenlight.guru

Sponsors:

Greenlight Guru

Today's episode is brought to you by Greenlight Guru, the only MedTech-exclusive Quality Management Software designed with the direct input of industry insiders. Dealing with cumbersome product development cycles? Facing the maze of regulatory compliance? Greenlight Guru is your guiding light. Our comprehensive software...

In this insightful episode, Eric Henry and Etienne Nichols delve into the evolving landscape of AI in MedTech, focusing on regulatory compliance and the future of AI in medical devices. They discuss the role of the FDA, FTC, and other regulatory bodies, and explore the implications of AI in product development and quality assurance.

1. "We're seeing pushes into adaptive algorithms... algorithms that modify themselves in the field without human oversight." - Eric Henry
2. "The FDA and other regulators are no stranger to the issues in generative AI as well." - Eric Henry
3. "Keep an eye on the FTC... they have a tool called algorithmic disgorgement, which can have significant implications for AI in life sciences." - Eric Henry

1. FTC's Growing Role: The FTC may soon have broader enforcement authority over AI across various industries in the U.S.
2. Algorithmic Disgorgement: A tool that allows the FTC to force companies to delete an algorithm and all its associated training data.
3. Evolving Regulatory Landscape: The FDA is adapting its regulatory framework to accommodate AI, focusing on adaptive and generative AI.
4. Challenges with Locked Algorithms: Current regulatory frameworks primarily support locked algorithms, but there's a movement towards adaptive algorithms.
5. Impact of AI on Quality Systems: AI is set to revolutionize quality management systems and manufacturing processes in the life sciences.
6. Importance of Pre-Market and Post-Market Oversight: Both are crucial for ensuring the safety and efficacy of AI-driven medical devices.
7. The Role of CSA in AI Integration: The transition from CSV to CSA could influence how AI is integrated into software systems.
8. Harmonization of Standards: A significant challenge in AI regulation is the harmonization of numerous standards being developed globally.
9. Public-Private Partnerships: Collaborations like the AI Global Health Initiative are vital for advancing regulatory frameworks in AI.
10. The Need for Industry Engagement: Active involvement in AI-focused organizations can help businesses navigate the evolving regulatory landscape.

• Visit www.greenlight.guru for insights on streamlining product development in Medtech.
• Follow Eric Henry on LinkedIn for updates on AI, quality systems, and regulatory compliance.
• Explore the AI Global Health Initiative under AFDO and RAPS sponsorship.
• For questions or consultations, contact Eric Henry at ehenry@kslaw.com
• Visit Greenlight Guru to learn more how to prepare your QMS for the future of MedTech.

Listeners are encouraged to leave a review on iTunes and reach out to Etienne Nichols on LinkedIn for feedback.

In this episode of the Global Medical Device Podcast, we’re joined by Elena Kyria, a talent acquisition specialist and CEO of Elemed. Elena delves into what it takes to climb the career ladder in the medtech industry, whether you're early or late in your career journey. Our host, Etienne Nichols, engages in a rich discussion on career paths, leveraging personal strengths, and the importance of networking and personal branding.

Quotes

1. "If you're not talking about the value that you add, how is anybody going to know what impact you're having?" - Elena Kyria
2. "Everything's uncertain really, isn't it? What you've got to have is a clear sense of forwards and just have a goal." - Elena Kyria
3. "Nobody goes to the gym and looks at the weights and gets fit. You have to do the reps." - Elena Kyria

Takeaways

1. Networking is Key: It's not just what you know, but who knows you and what they know you're doing.
2. Visibility of Achievements: Share your successes within your company; if you don't, others may not recognize your contributions.
3. Defining Success: Success doesn't always mean reaching the VP level; it's about personal satisfaction and contribution.
4. Strengths and Weaknesses: Focus on your strengths but be aware of your weaknesses and compensate with your team.
5. Career Paths: Understand the different career paths (leadership, expert, generalist) and what they entail for growth.
6. Communication Skills: Strong communication skills are paramount for leadership and for translating technical details to a broader audience.
7. Continuous Learning: Always seek new knowledge and experiences, no matter where you are in your career.
8. Adaptability: Be prepared to pivot and adapt to changes within the industry and your career.
9. Take Action: Don't just reflect on advice; apply it to make actual changes in your career approach.

Reference Links:

• Elena Kyria's LinkedIn
• Elemed
• Working Genius
• Greenlight Guru
• Etienne Nichols' LinkedIn

Remember to engage with the hosts and guests on LinkedIn for feedback and further discussions.

Don’t forget to leave a review on iTunes!

*Interested in sponsoring an episode? Use this form and let us know!

In this insightful episode of the Global Medical Device Podcast, host Etienne Nichols engages with Carmen Brown, the regulatory and quality affairs manager at Proxima Clinical Research. They delve into the specifics of In Vitro Diagnostics (IVDs) and explore the challenges and considerations faced by medical device manufacturers in the IVD pathway. Whether you're an industry veteran or new to the field of medical diagnostics, this conversation will enlighten you about the nuances of IVD regulatory compliance, risk assessment, and FDA interactions.

Episode Highlights:

1. IVDs are a Specialized Medical Device: Learn how IVDs, which include reagents, instruments, or systems for diagnosis, differ from other medical devices and what specific regulatory pathways they follow.
2. Risk Levels in IVDs: Understand the significance of classifying IVDs into class one, two, or three based on the risk of false or inaccurate results, and how this impacts regulatory strategy.
3. Pitfalls in Performance Characteristic Evaluation: Discover the complexities involved in evaluating the performance of multiband diagnostics and why traditional measures like sensitivity and specificity may not suffice.
4. Likelihood Ratios Over Sensitivity and Specificity: Grasp why likelihood ratios are a more appropriate statistical measure for multiband diagnostics and how they relate to pretest and posttest probabilities.
5. Clinical Relevance is Key: Recognize the importance of ensuring that the markers detected by IVDs are clinically meaningful and relevant to the condition being diagnosed.
6. FDA's Expectations for IVDs: Gain insights into the specific data and performance characteristics the FDA looks for in IVDs and the necessity of clinical data in regulatory submissions.

Quote:

"With IVDs, you're looking at it from the perspective of what's the risk of a false result or an inaccurate result. So you're looking at who's interpreting the results and the type of condition." ~Carmen Brown

Reference Links:

• Carmen Brown
• Proxima Clinical Research
• Greenlight Guru
• Etienne Nichols' LinkedIn

*Interested in sponsoring an episode? Use this form and let us know!

In this insightful episode of the Global Medical Device Podcast, host Etienne Nichols engages with Morven Shearlaw, co-founder of Fearsome, in a thought-provoking discussion on the essence of human-centered design in medical devices.

Delve into the importance of understanding user needs beyond surface-level assumptions and learn how Fearsome's approach to product development is setting new standards in MedTech.

From Glasgow's design desks to global market impacts, this episode is a deep dive into making MedTech better by truly connecting with the end-user experience.

Noteworthy Points:

1. The Pitfalls of Premature Solutions: Morven emphasizes the need for extensive user understanding before jumping to design conclusions, challenging the common industry haste to offer solutions.
2. The Evolution of Fearsome: Morven shares the growth story of Fearsome from a broad design firm to a specialized MedTech developer, emphasizing the value of a diverse industry background.
3. The Nuances of Usability: The conversation reveals the stark differences between consumer product design and medical devices, particularly the rigorous safety and risk management requirements in MedTech.
4. Defining the User: A deep dive into identifying the 'user' in medical device design, considering all stakeholders, from clinicians to patients and even those involved in device maintenance.
5. Real-world Feedback and Its Impact: Morven recounts a powerful anecdote where candid feedback from clinicians significantly redirected a product's development path.
6. The Risk and Reward of Human Factors: An exploration of how human factors, beyond safety, can become a competitive edge and a catalyst for enjoyable product experiences.
7. Regulatory Hurdles and Human-Centered Design: A critical look at the intersection of regulatory standards and human-centered design, advocating for earlier and more integrated human factors consideration.

Quote:

"Quality management is about quality, it's not just about proving that you can sell in the market because you've got a certain certification." - Morven Shearlaw

Reference Links:

• Morven Shearlaw
• Fearsome
• Greenlight Guru
• Etienne Nichols' LinkedIn

*Interested in sponsoring an episode? Use this form and let us know!

This episode of the Global Medical Device Podcast delves into the world of FDA submissions, specifically focusing on the eSTAR program. Host Etienne Nichols leads an insightful discussion exploring the intricacies, benefits, and strategies for using eSTAR effectively in medical device regulatory submissions.

To discuss this topic, we brought in the following experts:

• Patrick Axtell, Ph.D., the Senior Tools & Templates Engineer for the Office of Regulatory Products at CDRH
• Lisa Pritchard, Vice President of Regulatory, Quality, Clinical and Engineering at DuVal & Associates
• Kathy Herzog, Senior Regulatory, Quality & Compliance Consultant at DuVal & Associates

As of now, all 510K submissions must use the eSTAR program. eSTAR is designed to streamline the FDA submission process, making it more efficient and standardized. This episode is a must-listen for anyone in the medical device industry looking to navigate the complexities of FDA submissions with a focus on the evolving eSTAR program.

Expert Insights:

• Patrick Axtell: Discusses the development of the eSTAR program, its purpose, and benefits, including standardization and automation in the submission process.
• Lisa Pritchard: Shares her 30-year experience in regulatory space and her initial skepticism about eSTAR, which later transformed into advocacy for the program.
• Kathy Herzog: Provides practical advice on using eSTAR, emphasizing the importance of understanding and navigating the program effectively.

Key Strategies:

• Use the help features within eSTAR as a quality control check.
• Start at the beginning of the template to avoid missing critical sections.
• Prepare your submission content outside eSTAR before populating the template.
• Consider the executive summary as a mandatory, not optional, part of your submission for effective advocacy.

Future of eSTAR:

• eSTAR is evolving to include more types of submissions (e.g., PMAs, presubs) and may soon incorporate AI and other technological advances for enhanced efficiency.

Quotes:

1. "Standardized submission means that the reviewer can quickly find information...a huge benefit for both applicants and reviewers." - Patrick Axtell
2. "Even after 30 years, I always open those help boxes in eSTAR...each submission is unique." - Lisa Pritchard
3. "The key with eSTAR is eSTAR(t). You just have to get started...no substitute for just getting familiar with the template." - Kathy Herzog

Reference Links:

• Lisa Pritchard
• Kathy Herzog
• Etienne Nichols
• Greenlight Guru
• DuVal & Associates
• Client Alert: "eSTAR & I"
• FDA eSTAR Program webpage
• FDA electronic Submission Template guidance for 510(k) Submissions

In this episode, we delve into the burgeoning world of artificial intelligence in MedTech. Listen as we discuss the skepticism and opportunities associated with AI, the revolutionary impact on product development, and provide practical advice for professionals looking to harness AI's potential.

Wade Schroeder, Medical Device Guru for Greenlight Guru, shares his expertise on MedTechs AI-powered tools that are redefining risk management and compliance. With a keen focus on the AI in MedTech Trend report, this conversation is a must-listen for those ready to lead at the forefront of medical device innovation.

Check out the full report and explore the resources mentioned in this episode by visiting the Reference Links below.

Episode Highlights:

1. AI is still in its early stages within the MedTech industry, with potential to save time and improve efficiency.
2. There is a noticeable skepticism about AI, with 65% of respondents doubting the accuracy of AI data.
3. Corporate executives are the highest users of AI at 60%, with manufacturing operations at 50%.
4. Product development and engineering, as well as clinical sectors, are also incorporating AI significantly.
5. Quality and regulatory sectors are the least to adopt AI, possibly due to trust issues in AI's data accuracy.
6. Early adopters of AI in MedTech, akin to early CAD users, may gain a competitive edge in the industry.
7. The development of AI tools like Greenlight Guru's risk intelligence can specifically aid MedTech professionals by streamlining processes like risk assessment.

Quote:

"It's kind of like an iceberg we're seeing the tip of the iceberg with the use of ChatGPT for manipulating your email, when in reality there's this whole other world under the water." - Wade Schroeder

Reference Links:

• Wade Schroeder on LinkedIn
• AI in MedTech Report 2023
• Digital Guru
• Greenlight Guru
• Etienne Nichols on LinkedIn

Interested in sponsoring an episode? Click here to learn more!

In this episode, we delve into the multifaceted aspects of advisory roles within medical device startups. These discussions explore the nuanced differences between consulting and advisory work, the intricacies of the advisor-startup relationship, strategies for growth, and the delicate balance of equity and compensation in these roles. Devon Campbell shares invaluable advice and experiences, focusing on mentorship, relationship-building, risk management, and navigating the challenges of the MedTech startup ecosystem.

Some of the highlights of this episode include:

1. The distinction between consulting and advisory roles, highlighting the long-term, relationship-focused nature of advisory work.
2. The critical role of experience and mentorship in guiding startups, enhancing their growth and success.
3. Strategies to transform challenges into opportunities, fostering innovation and resilience in the MedTech industry.
4. The importance of understanding and respecting employment contracts and avoiding conflicts of interest in advisory roles.
5. The necessity of due diligence and setting high standards in choosing companies to advise, to protect one's reputation.
6. The power of passive networking and the proactive seeking of advisors to fill knowledge gaps, especially in areas like quality systems.
7. Insights into equity and compensation in advisory roles, emphasizing realistic expectations and adequate self-compensation.
8. The value of accelerator programs like MassChallenge in connecting startups with experienced mentors and advisors.
9. The importance of risk management and the strategic formation of diverse advisory boards to provide multifaceted guidance.

Quote:

"Having a board of diverse advisors can significantly enhance the quality of advice and direction for a startup." – Devon Campbell

Reference Links:

• Devon Campbell
• Prodct
• Greenlight Guru
• Etienne Nichols' LinkedIn

*Interested in sponsoring an episode? Click here to learn more!

Description:

In this episode, we discuss with with regulatory expert Mike Drues to dissect the evolving landscape of FDA medical device regulations. These discussions provide a comprehensive overview of the historical context and current implications of FDA guidances, with a particular focus on 510K predicate selection, clinical data requirements, and the nuances of permanent implants. The conversations address the challenges and complexities inherent in aligning medical device design and development with contemporary FDA expectations and offer invaluable insights for professionals in Product Development, Quality Assurance, and Regulatory Affairs.

Some of the highlights of this episode include:

1. How the 510K, originally an exception, has ironically become the predominant pathway in medical device regulation.
2. That, despite efforts to raise regulatory compliance standards, the enforceability of current guidances is limited due to unchanged regulations.
3. Discussion of FDA's non-binding guidances balance between being commendable for clarity and somewhat overreaching, reflecting a nuanced industry challenge.
4. How evolving FDA thinking underscores the importance of aligning with contemporary standards, going beyond mere compliance.
5. That selecting predicates with past design-related recalls for 510K submissions poses legal challenges and necessitates reevaluating older predicates in light of new risks.
6. How clinical data requirements in medical device regulation are dictated by engineering and biological factors, not just regulatory pathways.
7. How demonstrating substantial equivalence can be complex, and small technological differences must not introduce new safety concerns.
8. The definition of 'permanent implant' challenges traditional understanding, emphasizing the importance of biocompatibility and safety in regulation.

Quote:

"Just because you're meeting the standard, that just means that you're passing... That doesn't necessarily mean that you're making a safe and effective product." – Mike Drues

Reference Links:

• Mike Drues
• FDA Guidance: Best Practices for Selecting a Predicate Device to Support a Pre-Market Notification [510k] Submission
• FDA Guidance : Recommendations for the Use of Clinical Data in Premarket Notification [510(k)] Submissions
• FDA Guidance: Evidentiary Expectations for 510(k) Implant Devices
• Greenlight Guru
• Etienne Nichols' LinkedIn

*Interested in sponsoring an episode? Click here to learn more!

Description:

In this episode, Ellie Reynolds, Associate Director of Quality Assurance and Regulatory Affairs at Proxima Clinical Research, dives deep into the complexities of FDA submissions for medical devices.

She sheds light on the nuances of different submission types, such as 510K, De Novo, and PMA, and underscores the criticality of timelines, strategic planning, and a robust Quality Management System (QMS).

Reynolds also guides listeners through effective FDA interactions, the eSTAR system, and the significance of building relationships with review teams. Her expertise illuminates the path to successful FDA submissions, emphasizing preparation, organization, and proactive engagement with regulatory bodies.

Some of the highlights of this episode include:

1. Strategic alignment of clinical trials with market launch timelines is crucial for successful FDA submissions.
2. Differentiating between submission types (510K, de novo, PMA) and how they are essential for navigating the regulatory landscape.
3. Early interactions with the FDA through Q submissions and how those interactions streamline the market submission process.
4. The importance of understanding and managing FDA review timelines, including potential pauses and extensions.
5. How utilizing eSTAR helps identify documentation gaps and assess submission readiness.
6. How pre-submission meetings with the FDA are instrumental in addressing potential gaps and receiving regulatory pathway guidance.
7. The importance of comprehensive preparation and organization facilitate expedited FDA review, despite uncontrollable factors.

Quote:

"Interact with FDA early and often. It's what ultimately will make your submissions as seamless as possible." - Ellie Reynolds

Reference Links:

• Ellie Reynolds LinkedIn
• Greenlight Guru
• Etienne Nichols LinkedIn

*Interested in sponsoring an episode? Use this form and let us know!

Description:

Dive into the enlightening world of FDA inspections with Etienne Nichols and Mike Drues. In this comprehensive episode, the duo decodes the essence of effective communication, the importance of managing expectations, and the art of proactive dialogue with the FDA. They reveal insights that every MedTech professional must know, breaking down the philosophy, challenges, and expectations surrounding inspections, all while blending unique "Mike Drues isms" and Etienne's candid takes.

Some of the highlights of this episode include:

1. Grasping the art of proactive communication with the FDA, laying the foundation for regulatory success.
2. Delving into the essence of managing FDA's expectations during pivotal conversations.
3. Exploring the unpredictability of FDA inspections and the mantra of always being prepared.
4. Differentiating between inspections for class two/lower medical devices and class three devices.
5. Unpacking the role of FDA registration in attracting the FDA's attention for inspections.
6. Achieving the perfect equilibrium when providing information during inspections.
7. Navigating through concerns raised by FDA reviewers and appreciating the value of swift responses.
8. Navigating the nuanced gray areas, ranging from "sufficient investigation" to acknowledging and rectifying errors.
9. Unveiling real-world scenarios where complaints in medical device manufacturing are addressed effectively.

Quote:

""The solution to most problems is more communication, not less." - Mike Drues

Reference Links:

• GG Academy - use Promo Code "podcast25" for a 25% discount
• Greenlight Guru
• Vascular Sciences
• Michael Drues LinkedIn
• Etienne Nichols LinkedIn

*Interested in sponsoring an episode? Use this form and let us know!

Description:

In this episode, host Etienne Nichols and Shannon Bennett, a regulatory affairs expert in the diagnostic testing space dive into the FDA's proposed rules for Laboratory Developed Tests (LDTs) and In Vitro Diagnostic products (IVDs).

Shannon breaks down the past and present regulatory landscapes of LDTs, the differences between IVDs and LDTs, and what the FDA's changes could mean. They discuss the cost implications and the learning curve for labs new to FDA's processes.

Shannon explains the FDA's four-year phased plan for labs to comply with the new rules, touching on the challenges at each phase, like the administrative burden and the influx of submissions the FDA might have to review. Focusing on the transition for new or modified tests, Shannon emphasizes the need for more guidance from the FDA and educational efforts to help labs understand the new terms and requirements. We also discuss the potential disruption to healthcare and urge labs to actively comment on the draft regulations to the FDA.

Through engaging dialogue, this episode is a deep dive into the regulatory shifts in the lab industry, making it a great listen for those in the regulatory and healthcare fields.

Some of the highlights of this episode include:

1. Concerns regarding the handling of new or modified tests during the four-year phase-in period, emphasizing the need for clear guidance alongside historical tests.
2. Discussion on a unique approach from the Valid Act called technology certification, aimed at easing submission and review burdens on both labs and the FDA.
3. The significant educational effort required from the FDA to help labs navigate new terminologies and requirements.
4. The potentially disruptive impact on healthcare, given the critical role laboratory testing plays.
5. Encouragement for labs to actively provide comments on draft regulations to the FDA, advocating for a balanced approach to regulatory developments.
6. Year One: The focus is on adverse event reporting, with Shannon suggesting additional FDA guidance to manage irrelevant adverse event reports.
7. Year Two: registration and listing phase is discussed, pointing out the clerical burden on labs despite having most required information.
8. Year Three: The introduction of Quality System Regulation (QSR) or Good Manufacturing Practice (GMP) requirements in year three is explored, with Shannon mentioning some overlap with existing CLIA compliant quality systems but highlighting FDA's additional documentation expectations.
9. Year 3.5 & 4: Shannon delves into the submission of Premarket Approval Applications (PMAs) for high risk, low, and moderate risk tests in year three and a half and year four, underlining the challenge for labs in categorizing their tests and for the FDA in handling a potential influx of 80,000 to 100,000 new submissions.

Quote:

"I think the bottom line is this will be potentially very disruptive to the healthcare environment. Lab developed tests. There are studies that have shown that 70% of the information in the medical record is due to laboratory testing. So obviously, they play a really important role in the healthcare environment." - Shannon Bennett

Reference Links:

• Shannon Bennett on LinkedIn
• IVDs and LDTs: What’s the Difference?
• FDA Proposes New Rule to Regulate LDTs...

Description:

In this episode, we discuss the past, present, and future state of EUDAMED. EUDAMED is the European Database for Medical Devices, and is part of the European Medical Device Regulation.

While the EUMDR may have been published in 2017, many companies are still unsure how to handle the submission of their UDI (Unique Device Identification) data.

Joining us to discuss this topic is Richard Houlihan, an international speaker and guest university lecturer on EUDAMED.

His time running the European Commission IT teams developing EUDAMED has given him unrivalled insights into how EUDAMED affects the MedTech industry. This EUDAMED experience and his 28 years in IT give him a real advantage when helping companies prepare for EUDAMED, FDA GUDID, and other regulatory submissions.

His company EirMed with the website eudamed.com provides ongoing EUDAMED and regulatory submission support, training, an EUDAMED mobile search app, and software to help Manufacturers, Importers, European authorised reps, and Distributors meet their EUDAMED obligations.

To date, Richard and his team have trained over a thousand people on EUDAMED and helped hundreds of companies with EUDAMED consultancy and their regulatory data submissions to EUDAMED.

We hope you enjoy this episode on EUDAMED!

Some of the highlights of this episode include:

1. After the European Commission's EUDAMED working group meeting in June 2023 and the publication of the minutes, we know that the legally required audit of EUDAMED will now take up to nine months and is to be completed in Q4 2024.
2. Six months after the OJEU publication, EUDAMED will be deemed fully functional and EUDAMED will be mandatory. EUDAMED vigilance reporting for serious incidents will be mandatory from that point, Q2 2025 - the day after EUDAMED is fully functional.
3. EUDAMED’s fully functional date is now expected to be Q2 2025. Ireland and France have already made EUDAMED mandatory for new products.
4. For most medical device manufacturers, EUDAMED’s Actor, Device, and Certificate modules will be the only modules they'll use. These modules are already up and running. 

Quote:

"...it's a hugely ambitious project. Now, the device module and the certificates module, they're both huge in themselves. The vigilance module, that's a whole ecosystem in itself and the clinical investigations for any poor devil involved in clinical investigations, this thing is an absolute monster, it's huge. But what they've done is they're putting them all together and they're connecting them all - in the real world, we would call that consolidation in a marketplace... I was told it was the second biggest It project ever undertaken by the Commission." - Richard Houlihan

Reference Links:

• Richard Houlihan
• EirMed (eudamed.com)
• GG Academy - use Promo Code "podcast25" for a 25% discount
• Greenlight Guru
• Etienne Nichols LinkedIn

*Interested in sponsoring an episode? Use this form and let us know!

Description:

In this episode, we discuss how to select a site for a Clinical Trial.

Joining us for the conversation is Isabella Schmitt, MBA, RAC, the Vice President of Life Science Solutions at Proxima Clinical Research. Isabella brings a wealth of knowledge and experience in the intricacies of clinical study site selection, shedding light on the critical role it plays in MedTech product development.

In addition, we're joined by Samantha Pickett, an Associate Director at Proxima Clinical Research. Samantha dives deep into the key considerations for site selection, emphasizing the significance of patient demographics, regulatory compliance, and technological access.

This was a fun conversation as we discussed how to navigate the complexities of regulatory landscapes, explore collaboration strategies, share best practices, and draw insights from real-world case studies.

Some of the highlights of this episode include:

1. Why Site Selection Matters:

• In the realm of MedTech product development, site selection is the linchpin. It can make or break the trajectory of your innovation.
• Selecting the right geographic location and clinical trial site sets the stage for successful outcomes and paves the way for future success.

2. Key Considerations for Site Selection:

• Let's dig into the key considerations when selecting a site for your clinical study. Patient demographics, regulatory environment, and investigator expertise are vital factors.
• Infrastructure, access to cutting-edge technology, and the patient population at the site are equally critical aspects to consider.

3. Navigating Regulatory Landscape:

• Regulatory challenges can be formidable obstacles in the site selection process. We'll explore the complexities and implications these challenges can have.
• Tune in to learn about strategies that can help you navigate these hurdles, ensuring compliance and successful site selection.

4. Collaboration and Partnerships:

• Collaborating with research institutions, hospitals, and academic centers can be a game-changer. We'll discuss the numerous benefits this collaboration can bring to your site selection process.
• Moreover, we'll provide insights into strategies for establishing fruitful partnerships that enhance your site selection efforts.

5. Best Practices and Case Studies:

• Let's delve into real-world examples from the MedTech industry. We'll share success stories and case studies that illuminate the art and science of site selection.
• By extracting actionable insights and best practices from these examples, we aim to empower you in your own site selection endeavors.

Quote:

"Your aim should be to ensure everything aligns with expectations. The IRB's primary focus is patient protection, ensuring they comprehend the trial's details, risks, and benefits while safeguarding their privacy." ~Samantha Pickett

Reference Links:

• Samantha Pickett
• Isabella Schmidt
• GG Academy
• Greenlight Guru
• Etienne Nichols LinkedIn

*Interested in sponsoring an episode? Use

Description:

In this riveting episode of the Global Medical Device Podcast, Etienne Nichols brings together the dynamic leaders from Greenlight Guru: David DeRam (internally known as DD) and Pall Johannesson. Together, they embark on a journey through the chronicles of Greenlight Guru and SMART-TRIAL, exploring its growth, trials, and moments that defined its course. The conversation is sprinkled with heartfelt personal anecdotes, emphasizing the brand's commitment to unwavering quality and the pivotal shifts during the COVID-19 pandemic.

The trio delves into the intricate dance of nurturing a thriving work culture in the MedTech arena, especially amidst the waves of the changing remote work landscape. They share profound insights into navigating the maze of regulations in the medical device sector, underscoring the critical importance of resilience—captured by the evocative term "alligator blood"—to thrive in such a challenging environment.

Drawing the curtain back on the transformative world of medical technology, this episode is a deep dive into the role of mindset coaching, poignant patient stories, and the horizon of MedTech. With glimpses into AI's impending role and technological leaps, interwoven with light-hearted tales of branded socks, Etienne, DD, and Pall craft a narrative that underscores the core values and vision that propel Greenlight Guru forward.

Some of the highlights of this episode include:

1. A deep dive into why thriving in MedTech hinges on a fervent love for the mission, an unwavering dedication to the community, and an undying drive to champion quality of life.
2. The compelling origin story of Greenlight Guru, birthed from an unmistakable need to provide robust backing for medical device professionals.
3. The courageous pivot of Smart Trial: How they chose to scrap months of effort and boldly embrace the future with cutting-edge technology.
4. The resilience shown by Greenlight Guru during the COVID-19 storm: A seamless evolution from traditional office environments to adaptive global remote workspaces.
5. How, even in a virtual setting, Greenlight Guru maintained a palpable culture that not only kept the team connected but resonated profoundly with customers.
6. The blueprint for businesses in a post-COVID world: Understanding that adaptability and innovation aren’t just trends, but necessities for survival and growth.
7. An exploration into the challenges and opportunities presented by regulatory shifts: For the forward-thinkers, these aren't mere hurdles, but potential goldmines.
8. Why the term “Alligator blood” embodies the very resilience and fortitude required to chart the tumultuous waters of the MedTech industry.
9. The secret sauce of MedTech success: A strategic focus on investing in individuals defined by their grit, fiery passion, and boundless ambition.
10. A heartening reminder that MedTech’s real impact goes far beyond just technology—it's about making profound, tangible improvements in the quality of life.

Quotes:

"You have to fall in love with the space and the community and the patients, and the concept that improving the quality of life is everything if you're going to be successful here." - David DeRam

"We all have almost unlimited capacity. We can do pretty much anything that we want to do... It comes down to are we going to quit or are we not going to quit? We know what to do... Which is why we invest in Mindset coaching. We talk a lot about energy, we talk a lot about intention, and we built our team on that culture." - David DeRam

Reference Links:

• David DeRam LinkedIn

Description:

In this episode recorded in front of a live audience in Boston, MA, we speak with Christy Sheehy-Bensinger, the CEO & Founder of C-Light Technologies, Inc. about their recently cleared eye movement monitor. Listen as we unpack her journey from academia to startup life, explore the complexities of medtech communication, and delve into the intricate dance of securing FDA clearance. This was a fun conversation, with good Q&A at the end where we discuss the highs and lows of pioneering digital health solutions, the significance of a quality-first mindset in MedTech, and the art of crafting a passionate team.

Some of the highlights of this episode include:

1. Transitioning from academia to startup, and the demands of adaptability; navigating the real-world validation while staying solution-driven.
2. Navigating the regulatory landscape, and the marathon that it is and how being FDA-cleared is just one of the many milestones.
3. Building a quality-centric culture from day one to set the tone for long-term success in the MedTech space.
4. How building a startup is akin to fixing a plane mid-flight – it's challenging but passion and clarity make it feasible.
5. Tailoring communication, and how suiting it to the listener's background can be the game-changer in understanding and collaboration.

Quote:

"Management, speaking their language is super important. If I can compare it to what I already know, then that's easier." - Christy Sheehy-Bensinger

Reference Links:

• Christy Sheehy-Bensinger
• C-Light Technologies
• GG Academy - use Promo Code podcast25 for a 25% discount
• Greenlight Guru
• Etienne Nichols LinkedIn

*Interested in sponsoring an episode? Use this form and let us know!

Description:

In this episode, we explore the impact of software development methodologies in the medical device industry. With industry experts from HTD Health, we dissect the Agile approach to compliance, the intricacies of Quality Management Systems (such as Greenlight Guru), and go-to-market challenges for innovative medical devices.

Zach, CEO of HTD Health, is a self-taught software engineer turned serial entrepreneur. His first venture, Fresh Corner Cafe, served fresh food in Detroit's food deserts for eight years. He then founded HTD Health to craft digital health solutions, pioneering the shift to virtual care. The company supports care providers, device makers, and life sciences. Zach also founded Exos, a governance SaaS, and sold it in 2022.

Weronika Michaluk, a jack-of-all-trades in biomedical engineering, business, and public health, leads HTD's Software as a Medical Device unit. With degrees from Miami and Warsaw, plus a Doctorate in Public Health, she's worked on everything from wireless ECGs to digital health consulting. At HTD, her laser focus on quality and customer satisfaction drives organizational success.

Some of the highlights of this episode include:

1. An introduction to "Compliant Agile," a balanced methodology for MedTech development that prioritizes customer interaction while maintaining regulatory compliance.
2. The importance of choosing the right Quality Management System (QMS), highlighting the flexibility and feature-rich experience of Greenlight Guru.
3. The need for companies to focus on their core competencies while being adaptable and compliant.
4. The importance of a positive mindset and a well-defined success metric for any MedTech project.

Quote:

"Our mission is to make the industry more accessible, more human centric and more productive" - Zach Markin

Reference Links:

• HTD Health page
• HTD SaMD Insights
• HTD SaMD Chassis
• Zach Markin LinkedIn
• Weronika Michaluk LinkedIn 
• GG Academy
• Greenlight Guru
• Etienne Nichols LinkedIn

*Interested in sponsoring an episode? Use this form and let us know!

Description:

Join Devon Campbell in MedTech funding. He unveils startup red flags, from data integrity to product maturity. His message? Know your weaknesses, fill the gaps.

Considering cold-calling other Founders? It works. Understand your their investment landscape first. Recognize that VCs and Angels have different risk profiles. Devon says know your funding options and their strings. It’s about terms and expectations, not just money.

Think a sleek exterior hides internal flaws? Devon focuses on product readiness and QMS. Be manufacturing-ready and optimize. No shortcuts in MedTech.

In a red-tape world, paperwork matters. It's about confidence, not bureaucracy. Devon shifts focus to quality systems as confidence builders. His point? "Unquestionable, indelible data—that’s what I can trust." Get organized, and confidence becomes your MedTech currency.

Some of the highlights of this episode include:

1. Knowing your weaknesses. It's important to recognize your gaps and seek the right help.
2. Maintain data integrity. Full disclosure of data builds trust - no sugar-coating..
3. Evaluating product maturity - good looks aren't enough; be manufacturing-ready.
4. The importance of a strong Quality Management Systems (QMS). Document, document, document. No excuses.
5. Risk Management isn’t a checkbox: it's an ongoing pledge to safety.

Quote:

"Unquestionable, indelible data—that's what I can trust. That's confidence." ~Devon Campbell

Reference Links:

• Devon Campbell
• Prodct
• GG Academy
• Greenlight Guru
• Etienne Nichols LinkedIn

*Interested in sponsoring an episode? Use this form and let us know!

Description:

In this episode, Etienne Nichols and Ellie Reynolds explore FDA's Breakthrough Device designation. They discuss pursuing breakthrough status, aligning marketing strategies with FDA review, and navigating the medical device industry. This episode provides a roadmap for this complex regulatory terrain.

Learn about the benefits and scrutiny of the breakthrough designation, hear examples that emphasize the need for precise data and quality in the application process, and listen as we explain the planning and considerations for success, and how innovation can thrive within regulation.

Some of the highlights of this episode include:

1. The changes in CMS reimbursement, and how breakthrough devices no longer guarantee automatic CMS reimbursement.
2. Planning for FDA Submission, and how to align with FDA timelines.
3. Competitive Landscape - how achieving breakthrough is still possible, even if competitors have it.
4. Whether or not it's worth pursuing Breakthrough Designation.
5. The benefits of Breakthrough Designation Benefits (such as FDA priority review and potential marketing buzz).

Quote:

"Say you are a direct competitor with someone else, and they got breakthrough but they're not on the market yet... You can still get breakthrough for the same indication. FDA does not consider that as a cleared or approved alternative - even if they're miles ahead of you."

Reference Links:

• Ellie Reynolds LinkedIn
• Proxima CRO
• Etienne Nichols LinkedIn
• etienne.nichols@greenlight.guru
• GG Academy
• Greenlight Guru

*Interested in sponsoring an episode? Use this form and let us know!

Description:

In this episode of the Global Medical Device podcast, we discuss the intricate world of medical device regulations, design, and innovation. Hosted live in San Jose, the podcast features the esteemed Nada Hanafi, SVP - Regulatory Strategy at Veranex, who brings her rich experience of 12 years at the the FDA and Regulatory Strategy to discuss pressing issues and notable developments in the industry.

Join us as we delve deep into crucial topics such as biases in medical device testing, the evolving approach of the FDA, and the importance of user-centric design. This episode offers a comprehensive look into the dynamic and ever-evolving realm of medical technology, emphasizing the balance of innovation and regulation.

Highlights of the episode include:

1. Skin Tone Bias in Medical Devices: Nada Hanafi spotlighted the biases in pulse oximeters, shedding light on how these devices often fail to perform efficiently across varied skin tones. A lack of diversity in validation tests, mostly relying on Caucasian young men, resulted in compromised health outcomes for others.
2. Evolution and Transparency of the FDA: Nada traced the journey of the FDA, illustrating its transformation towards greater transparency and predictability. Emphasizing the human touch behind FDA's decisions, she dispelled the myth of the FDA being an impersonal "black box".
3. Global Regulatory Movements: Highlighting a shift in the MedTech landscape, Nada pointed to the trend of global regulatory harmonization, particularly noticeable in the realm of software-based medical devices.
4. Importance of User-Centered Design: Nada and the panel emphasized the significance of involving patients early in the design phase. Using tools like personas and human factor tables can lead to products that truly cater to users' needs, ensuring both usability and safety.
5. Embracing Learning in MedTech: Nada's hope for companies to learn from past oversights and adapt to changing regulations stressed the crucial role of iteration and learning in medical device innovation.
6. Navigating Modern MedTech Challenges: From addressing the significance of thorough documentation practices to discussing the challenges of regulating AI-driven medical devices, the discussion underscored the ever-evolving MedTech arena and the imperative need for regulators to stay updated.

This episode paints a comprehensive picture of the medical device industry, addressing both its challenges and its advancements.

Quote:

"Medical devices shouldn't be designed with a one-size-fits-all approach. We've seen firsthand the impact of biases, like with pulse oximeters. It's crucial that we validate devices across diverse populations to ensure safety and efficacy for all."

Reference Links:

• Nada Hanafi
• MedTech Color
• MedTech Innovator
• Veranex
• Etienne Nichols
• True Quality Roadshow
• Greenlight Guru Academy
• Greenlight Guru Software

Description:

During the Houston leg of our True Quality Roadshow series, we had the opportunity to sit down with Dan Purvis, CEO of Velentium and author of "28 Days to Save The World."

Dan tells the story of how his company weathered the early days of startup life, and how the pandemic - which took so many companies down - turned out to be the springboard that tested the culture that Dan and his co-founder had molded from the very beginning.

If you're not familiar with our True Quality Roadshow - you should definitely check it out! It's a free half-day event at one of 6 cities across the world. Links below!

Some of the highlights include:

• The role Velentium played in upscaling the production of ventilators during the pandemic - this was a significant achievement and showcases Velentiums leadership, collaboration, and company responsiveness during this worldwide crisis.
• Real-life challenges faced by companies, especially dramatic stories like the purchase of parts without a PO and the personal involvement of the leadership, and paint a vivid picture of commitment and dedication.
• The central theme of a company's mission ("We exist to change lives for a better world") and how it guides its decisions is foundational and deeply impactful.
• The pivotal role that company culture plays, even when compared to strategic planning.
• The long-term vision of a company, and we emphasize that while actions and technologies change, the core mission remains constant.
• The decisions Dan was faced with, such as how (or if!) to pay employees during a crisis, and we highlight the ethical considerations a company has to make, and how to stay aligned with a company's core values.
• The emphasis on finding clients to fund growth rather than relying on investors - this is not only pragmatic advice for startups but also provides a unique perspective on business growth.

Quote:

"Because as a leader, if you don't clearly know where you're headed, it's really hard to get a bunch of people to follow you. And I don't want people to follow me. I want them to race me up the mountain, which is the one that we've all decided to ascend together."

Reference Links:

• Dan Purvis LinkedIn
• 28 Days to Save The World book
• Etienne Nichols LinkedIn
• True Quality Roadshow
• Velentium
• Texas Medical Center for Innovation